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1INTRODUCTION
 India accounts for 20% of maternal deaths globally and it is
estimated that a woman is dying every 5 minutes due to obstetric
complications8. Maternal deaths are caused by obstetric complications like
postpartum haemorrhage, sepsis, unsafe abortion, toxaemias& obstructed
labour.
As per a report by WHO (World Health Organization) 2005, 25-
30% of maternal deaths are caused by postpartum haemorrhage (PPH)8.
Prevalence of PPH all over the world is approximately 6%4 & it is the
most common preventable complication of third stage of labour6.
 Third stage of labour begins immediately after delivery of foetus
(or) foetuses and it involves separation and expulsion of placenta with its
entire membranes7. Although the third stage of labour occupies a very
short duration, it is the most crucial period, as complications during this
stage may be hazardous to maternal life.
Postpartum haemorrhage may be due to various causes like bleeding
from implantation site due to atonic uterus, trauma (or) both.
 Traditionally Postpartum haemorrhage was defined as loss of 500
ml of blood or more after a vaginal birth or ? 1000 ml following
2caesarean birth or a fall of 10% hematocrit when compared to pre labour
value7. But 50% of pregnant women who delivered vaginally shed 500 ml
of blood (or) more when measured quantitatively.
Pitchard and associates reported that estimated blood loss is only
approximately half of actual loss. So any blood loss more than 500 ml
needs careful attention7. Although many factors predispose to atonic
postpartum haemorrhage, like multiparity, over distension of uterus,
antepartum haemorrhage & prolonged labour, two thirds of postpartum
haemorrhage occurs in women with no risk factors23. Hence all pregnant
women are at risk of postpartum haemorrhage.
Management of third stage of labour involves a careful look for
signs of placental haemorrhage soon after delivery of foetus/foetuses8.
 Usually signs of placental separation occur within five minutes after
delivery of baby. After placenta gets separated, state of uterus is examined
to find out whether it is firmly contracted or not. After expulsion of
placenta, it is examined thoroughly to find whether entire placenta has got
separated. Condition of the mother and the amount of bleeding are noted
carefully. This approach has been termed as physiological management of
third stage of labour7.
3It has been proved that active management of third stage of labour
prevents atonic haemorrhage. Usage of oxytocics reduces haemorrhage by
40%20.  Active management of third stage of labour (AMTSL) includes use
of uterotonic as soon as the baby is delivered (with in 1 minute), controlled
cord traction and uterine massage. AMTSL shortens the duration of third
stage of labour and by facilitating delivery of placenta it reduces the blood
loss14.
 Normal duration of third stage varies from 5-15 minutes and it is
shown in literature that, the best predictor of PPH,is a 3rd stage of labour
which lasts for more than 18 minutes20.
Normally after separation and expulsion of placenta, there will not
be any severe bleeding. This is due to immediate closure of the mouth of
severed maternal vessels by contraction and retraction of muscle fibres of
the middle layer of uterine musculature, which act as living ligatures.
 Placental cord blood drainage includes unclamping the previously
cut and clamped umbilical cord. The present study was undertaken to
evaluate the efficacy of placental cord blood drainage after vaginal
delivery as a part of management of the third stage of labour in reducing
the duration & blood loss during third stage of labour thereby preventing
postpartum haemorrhage.
4AIM AND OBJECTIVES
AIM:
            The present study is conducted to evaluate the efficacy of placental
cord blood drainage after vaginal delivery
1.In reducing the duration & blood loss during third stage of labour
2.In reducing the incidence of PPH.
OBJECTIVES :
            Postpartum haemorrhage is the most common cause of maternal
mortality and it complicates about 4% of vaginal and 6% of caesarean
deliveries9.
           It can be defined clinically as any amount of blood loss that results
in hemodynamic instability.
               Postpartum haemorrhage can turn the normal successful labour
into abnormal, within a minute.
             The best management of third stage of labour is the one that
effectively reduces the blood loss and postpartum haemorrhage, while not
interfering much with the physiological mechanisms of the third stage11.
5            Placental cord blood drainage after labour natural is a very simple
and non invasive method and does not need any costly equipment. So the
present study was undertaken to evaluate the efficacy of the above method
in reducing the blood loss during the third stage as a part of management
of the third stage.
6REVIEW OF LITERATURE
As per recent data (2009), Maternal Mortality Rate of India is 212 &
of Tamil Nadu is 7956.
 In developing countries, postpartum haemorrhage accounts for
more than 30% of all maternal deaths23.
 Prolonged third stage of labour is associated with increased
incidence of haemorrhage.
The duration of third stage blood loss, incidence of postpartum
haemorrhage was reduced in placental blood drainage group. (Gulati et al
al - Journal of O&G of India 2001:51)17
Sharmal et al (Archives of Gynaecology & Obstetrics – 2005)
reported that duration of third stage of labour is significantly reduced in
both primi and multigravida following cord blood drainage18.
A  randomized controlled trial of placental blood drainage after
spontaneous vaginal delivery( Indian Journal of Obstetrics and
Gynaecology- volume 57- no: 3 May/June 2007 conducted by Shravage
JC, Silpa P,  at J.N.Medical College, Belguam)15 showed that the  duration,
7blood loss and incidence of postpartum haemorrhage was reduced in the
study group.
             In the placental cord drainage group, there is statistically
significant reduction in the duration of third stage of labour. Further
research is needed in a large scale randomized study to draw major
conclusions about the maternal outcomes like blood loss, incidence of
postpartum haemorrhage. (Cochrane Review 2009- Soltani H, Dickinson
F, Symonds IM)57
Placental cord drainage shortens the third stage of labour-
(Jongkolsiri.P, Manotaya.S 2009, and Journal of Medical Association –
Thai)13
 Placental cord blood drainage is a simple, safe, non invasive
method in reducing the duration & blood loss of third stage of labour
(Medical Journal of   Babylon – volume 7, No 3-4, 2010, pg 404-409)
Placental cord drainage reduces the third stage of labour and the
amount of blood loss. But no difference is noted in the blood transfusion
rate and the risk of postpartum haemorrhage ( Cochrane review 2011-
issue 9 by Soltani H, Hutchon DR)3.
A Similar study showed that placental cord drainage reduces
duration & blood loss during the third stage of labour. (French Cochrane
Centre – 12th November 2012)2
8 Effectiveness of placental drainage (PLADRAINAGE) - a
randomized clinical trial  published at clinical trials. gov (US National
Institute of Health ), last updated on June , 20131 where the study was
completed & results awaited
9PHYSIOLOGY OF THIRD STAGE OF LABOUR
Understanding the physiology of third stage of labour is very
important in the correct management of complications of third stage.
Third stage of labour begins soon after the delivery of
foetus/foetuses and involves separation and expulsion of placenta with its
entire membranes (Williams 23rd Pg. 146).
Conduction of third stage of labour should not be hurried, because
after a very few minutes of delivery intense retraction of uterus occurs.
CAUSES OF PLACENTAL SEPARATION
Sudden decrease in the uterine size following delivery leads to
decrease in the area of placental implantation site and the placenta
increases in thickness to accommodate this reduced area.  But as the
placenta is less elastic, it is forced to buckle and the resulting tension
pulls the deciduas .Hence placental separation follows because of
disproportion between the size of placenta and the implantation site57.
Separation of foetal membranes follows as a result of greater decrease in
the uterine cavity. Normally, placenta separates within few minutes after
delivery.
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Placental separation is mostly due to the mechanical effect of
shearing, as the bulk of placenta cannot accommodate itself to the reduced
placental site which is almost up to 10 cm or less9.
Normally there will not be much resistance at the plane of cleavage.
However the membranes are often very adherent and as there is no
appreciable bulk, they are not sheared off the uterus by retraction/reduction
in the surface area (Ian Donald).
After the delivery of the foetus, separation of placenta takes place.
Shrinkage of the placental site followed by forcing downward of whole
placental mass by the contraction of uterus leads to placental separation.
(Mudaliar & Menon).
ULTRASOUND STUDIES  OF PLACENTAL SEPARATION:
Herman et al40 showed ultrasonographically that shearing forces
upon the interface between placenta & myometrium depends on retro
placental myometrial contraction.  He divided the third stage into the
following four phases based on ultrasonogram appearances.
1. Latent phase;
Immediately follows delivery of the baby.
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Myometrium contracts except retroplacental area which remains
relaxed.
2. Contraction phase;
Retroplacental myometrium contracts.
3. Detachment phase;
Placenta is sheared off the decidua.
4. Expulsion phase;
As a result of uterine contraction, placenta is expelled from the
uterus.
Contraction that occurs prior to delivery of foetus, will not cause
placental separation, as the myometrium is not having the necessary strain
for placental detachment41.
 SIGNS OF PLACENTAL SEPARATION: (Williams 23rd Edition, pg:
397)
1. Uterus becomes firm and globular.
2. Sudden gush of bleeding.
3. Placental bulk in lower segment pushes the uterus upward.
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4. Lengthening of  infra vaginal portion of umbilical cord occurs because
of descent of placenta.
These signs appear within 1 minute – maximum up to 5 minutes.
METHODS OF PLACENTAL SEPARATION:
Schultze  method – central separation9:
 Central portion of the placenta got separated first followed by a
concentrically enlarging area so that the placenta bulges   presenting the
centre of foetal surface.
Earlier it was thought that this is due to collection of blood, behind
the centre of placenta. But now it is recognized that this retro placental
haematoma is the result of separation rather than the cause of separation.
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Matthews Duncan’s method – Peripheral separation9:
The whole placenta is sheared off the uterine wall and it descends
sideways. The placenta may be folded on itself and the inferior margin of
the placenta presents first (i.e., maternal surface of the placenta appears
first).Blood escapes between the uterine wall and the separating placenta.
BLEEDING AFTER PLACENTAL SEPARATION  IS ARRESTED
BY FOLLOWING MECHANISMS  :
At term around 500-800 ml of blood is circulating through the
placenta. After the separation of placenta this has to be arrested within
seconds or otherwise profuse haemorrhage will occur.
Bleeding after placental separation is arrested by (Arulkumaran,
Management of labour, pg.286)
1. Contraction and retraction of uterine oblique muscle fibres around
the blood vessels (like figure of 8) which causes compression.
2. Close apposition of uterine walls
3. Coagulation and fibrinolytic mechanisms are activated enormously
around the placental site.
Two hormones are essential for the contraction of uterus after
delivery of the foetus namely oxytocin and prostaglandins .Effects of these
two hormones can be instantaneous. However if this effect does not occur
14
properly, then there will be bleeding from the placental site due to
atonicity of uterus .The occurrence of atonicity is unpredictable and
episodic. Many women having known risk factors deliver with minimal
amount of blood loss, whereas others without any risk factors may bleed
profusely after delivery4.
 The above cited mechanisms are aided by coagulation events at the
placental site, whereby contraction and retraction of uterus causes
mechanical occlusion of arterioles, thereby facilitating placental plug
formation and activation of clotting cascade & fibrinolytic mechanisms.
(Current progress in obstetrics & gynaecology, Jhon Studd, 2012,
Volume 1)
Contraction of uterus causes ligation of oblique muscles around
blood vessels, so that the blood cannot return back in to the maternal
circulation. Congested veins rupture & sheer off the decidua
basalis.(Cunningham 2001 : Fraser 2003)
EXPECTANT MANAGEMENT OF THE THIRD STAGE OF
LABOUR8:
1. Waiting for signs of separation of placenta to occur.
2. Allow the placenta to deliver spontaneously (or) by gravity.
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CLAMPING OF UMBILICAL CORD7 (Early versus delayed):
 - Two clamps are placed 4-5 cm from the foetal abdomen and the
umbilical cord is cut in between.
    - Cochrane Database review – Mc Donald Middle ton (2008)
reported that delayed cord clamping up to 1 minute, increased the
haemoglobin concentration by 2.2g/dl while compared with early clamping
within 60 seconds. At the same time, early clamping reduced the risk of
hyperbilirubinemia and the need for photo therapy by 40%.
- As per Williams’s textbook of   obstetrics – Early clamping of
umbilical cord is followed, as a routine.
 In normal physiology of the third stage where umbilical cord is not
clamped, blood in the placental compartment drains in to the baby & this
placental transfusion will be completed within 2-5 minutes after delivery.
(Farrar 2011).From mother, s view point, immediate unclamping of the
cord & drainage of cord blood is close to the physiological process3.
Although it may be an intervention, it is much less than maintaining the
clamping until delivery of placenta (Cochrane review 2011).
DELIVERY OF PLACENTA:
? It should not be attempted before the signs of placental separation.
? Traction on umbilical cord to pull the placenta should be avoided.
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? Umbilical cord is kept slightly taut and uterus is lifted cephalad with
the other hand and it is repeated until placenta reaches introitus.
(Prendivillie and associates, 1986)
? Draining of cord blood reduces the bulkiness of placenta & allows
the uterus to contract and retract, thereby aids in placental
delivery (Wood 1997)37
Placental blood drainage is recommended in the expectant
management of labour – Hinching brooke trial (Rogers 1998).
Retained Placenta :
There is no consensus regarding the time after which a placenta is
said to be retained. Usually if the placenta is not delivered even after thirty
minutes to one hour after delivery it is called as retained placenta11.
Conventional treatment for this is to start an oxytocin drip ,followed
by manual removal under regional/general anaesthesia.
In rare cases if the placenta is not delivered with in this period it
may be due to morbid adherence of placenta as in placenta accreta/
increta/percreta with an absence of plane of cleavage.
Cochrane review showed that umbilical oxytocin can be used
effectively for the management of retained placenta42. For this Pipingas
technique may be followed. In this technique, oxytocin is diluted in 30 ml
17
of saline & injected along umbilical vein using infant nasogastric feeding
tube43.
Pipingas Technique
In our study, placenta is considered as retained, if it is not separated
within 30 minutes & those cases were excluded from the study.
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ACTIVE MANAGEMENT OF THIRD STAGE OF LABOUR
(AMTSL)
THREE COMPONENTS14
1. Use of  uterotonics within 1 minute of delivery of baby.
2. Controlled cord traction.
3. Uterine massage.
AMTSL20
1. By facilitating delivery of placenta, the duration of third stage of labour
is shortened thereby reducing the blood loss, leading to effective uterine
contractions.
2. By avoiding uterine atonicity, PPH can be prevented. Third stage of
labour that lasts 18 minutes or more is the best predictor of PPH & that is
why early delivery of placenta is important.
 Originally early cord clamping was included in active management
of third stage of labour, but the timing of cord clamping has very little
impact on the incidence of postpartum haemorrhage. A randomised control
trial conducted by Ceriani Cernadas JM concluded that there was no
significant difference in the incidence of postpartum haemorrhage
associated with the timing of cord clamping23.
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However immediate cord clamping may reduce the amount of red
blood cells received by the new born, whereas delayed cord clamping is
associated with less incidence of intra ventricular haemorrhage, anaemia
and late onset sepsis especially in preterm babies29,30 .For these reasons,
the collaborative ICM/FIGO Group did not include early cord clamping in
the active management protocol.
 Active management of third stage facilitates the delivery of placenta
by increasing uterine contraction and prevents post partum haemorrhage
by averting atonicity of uterus23.
Active management of third stage of labour reduces the following23;
1. Risk of post partum haemorrhage.
2. Postpartum anaemia.
3. Prolonged third stage of labour.
4. Blood transfusion requirements.
5. Use of therapeutic drugs for postpartum haemorrhage.
It is now recommended that AMTSL should be routinely practiced
in all maternity hospitals and also there is no evidence to suggest that this
should not include births at home or in health centres.
FIGO now advices if oxytocin or misoprostol is not available,
skilled birth attendants should practice expectant or physiological
20
management of third stage of labour. This means that they should not
begin cord traction before the uterus is well contracted and separation and
expulsion of the placenta has begun, so that it allows the mother to expel
the placenta spontaneously.
A Technical consultation held by the World Health Organisation for
the prevention of postpartum haemorrhage in 2006 recommends the
following23:
1.  Administration of uterotonic soon after delivery of the baby, controlled
cord traction and uterine massage should be included in active
management of third stage of labour.
2. Oxytocin should be preferred than oral /sublingual/rectal misoprostol for
prevention of post partum haemorrhage.
3.  As dreadful complication such as uterine inversion can occur following
inappropriate cord traction, active management of third stage of labour
should always be carried out by skilled birth attendants.
1. ADMINISTRATION OF OXYTOXIN AND OTHER
URETEROTONICS
? Oxytocin is the choice of ureterotonic.(10 units given
intramuscularly  within 1 minute of delivery&if needed 10-20 units
in 500ml of RL/NS ).
? It increases the amplitude and frequency of uterine contractions.
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? It acts within 2-3 minutes of administration (Gulmezoglu et al).
? Half life is about 3-5minutes.
?  Fluid retention and water intoxication can occur if it is given in
large volumes of electrolyte free IV fluids.
? Bolus intravenous injection can cause profound hypotension in term
women due to peripheral vasodilatation (Secher et al 1998).
SECOND GROUP OF OXYTOCICS – (includes methyl ergometrine)
? It increases the muscle tone of uterus by causing contraction of
myometrium compressing the myometrial blood vessels.
? Half life is about 120 minutes.
? It should be refrigerated.
? Safe effective dose is 0.2 -0.5 mg i.m./i.v.
? Major side effects include nausea, vomiting and hypertension.
? Contraindicated in hypertension, pre eclampsia &heart disease
complicating pregnancy.
THIRD GROUP – (includes prostaglandins. – PG F??, PG E1)
? They cause contraction of myometrium by increasing calcium
release from the cell.
? Misoprostol 800-1000?g is the 2nd line drug when PPH is not
controlled by oxytocin [Hofmeyr et al 2005].
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? Side effects include nausea, diarrhoea, vomiting, pyrexia
&shivering.
? PG F2 alpha [carboprost] is mainly used in intractable hemorrhage
when other measures fail .Usual dose is 250µg intra muscularly, and
it can be repeated every 15 minutes.
Either ergometrine or misoprostol should not replace oxytocin as a
routine in the active management of third stage of labour (Gulmezoglu
2002)
2.CONTROLLED CORD TRACTION20 :
? After delivery of the baby, wait till the cord pulsation stops.
? Apply first cord clamp on the umbilical cord ,4-6cm from the baby
and the second clamp next to it and closer to the mother .
? Cut between two clamps using sterile scissors.
Early cord clamping is done in following cases;
1. Premature babies –less than 36 weeks.
2. Asphxiated babies and where immediate
resuscitation is needed.
3. HIV (Human immunodeficiency virus) infected
mothers/Rh negative mothers.
4. If the bleeding is profuse.
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? With one hand the end of clamped cord is to be held and the other
hand is kept over the abdomen just above the pubic symphysis.
? Uterus is stabilized by applying counter pressure upward and
backward to prevent inversion.
? Encourage mother to push with the first strong contraction of uterus.
? Gentle controlled cord traction is applied to deliver the placenta.
Counter pressure on the uterus is applied continuously.
? If the placenta is not descended within 30-40seconds of controlled
cord traction then the cord is held gently and wait till the uterus is
well contracted.
? Controlled cord traction is repeated with next contraction along with
applying counter pressure on the uterus.
? As the placenta delivers it is being held in two hands and gently
turned in one direction causing the membranes to be twisted on
them until it is slowly delivered.
? If the membranes are not completely removed, then cervix is
examined gently with the help of sponge holding forceps to remove
any visible pieces of membranes.
? Make sure that the mother’s urinary bladder is empty. Controlled
cord traction is associated with less blood loss and shorter third
stage. (Enkin et al 1995).
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3. UTERINE MASSAGE20
? Soon after the delivery of placenta the fundus of the uterus is
massaged with the hand over the abdomen until it is contracted.
? This is to be done firmly enough to make the uterus to contract and
to expel the clots. But not so strongly, as it will cause pain.
? Ensure that the placenta was expelled entirely.
? Ensure that the uterus is not relaxed after stopping the uterine
massage.
? Palpate the uterus every 15 minutes and assure that the uterus is
contracted well.
? Women  are  to  be  taught,  how  to  check  that,  her  own  uterus  is
contracted and massage it by herself until it is well contracted.
? Repeat the uterine massage if needed.
? After separating the labia, the perineum &vagina are to be inspected
carefully for any lacerations.
? Inform the mother that she will feel cramps while giving
uterotonics.
? Throughout the procedure support & reassurance is to be given to
the woman.
Disadvantages of AMTSL57
1.  Increase in diastolic BP>100 mmHg.
2.  Increase in postpartum nausea, vomiting and headache
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ESTIMATION OF BLOOD LOSS20
1. Visual estimation.
2. Use of blood collection drape.
3. Use of Kanga method as in East Africa.
4. Blood collection in a kidney tray or other calibrated container.
Visual Estimation of Blood Loss
? It is not accurate.
? Published data showed that visual estimation of blood loss often
underestimated the PPH by 30 – 50% (Chau,et al)
? As the blood loss increases, the inaccuracy of visual estimation of
blood loss is also increased (Duthie et al).
? Hence, such under estimation of blood loss delays the diagnosis and
timely management if PPH occurs.
Kanga Method Of Estimation
? It was proved very effective in Tanzania.
? Standard Kangas are made up of large pieces of cloth of similar
weight, size and fabrics.
? They can be wrapped around the perineum by themselves.
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? It can be used in the lower level health facilities to estimate the
blood loss accurately.
? Studies proved that if two kangas are saturated with blood ,PPH can
be diagnosed accurately.
By Using Cholera Bed :
? It is also an effective method.
? For this, women’s buttocks will be placed over the hole in the bed,
and the baby delivers on to the bed rather than off the bed.
? A container (calibrated) should be placed under the hole in the bed.
? Using a gloved hand, all blood on the bed, must be collected in to
the hole
USAGE OF BLOOD COLLECTION DRAPE20
ADVANTAGES
? Plastic blood collection drape is a very simple device to assess the
blood loss.
? Immediately after assessing the blood loss, corrective measures can
be taken.
? Skilled birth attendants, at lower level health facilities, take initial
steps to stop the bleeding / begin fluid replacement / transfer the
mother to a higher institution.
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? Hospitals can start emergency management soon after the excessive
blood loss is recognised.
STRUCTURE
? It is a funnel shaped plastic bag, used for measurement of blood
loss.
? Upper rectangular portion to be placed  under women’s buttocks
? Funnel shaped/ triangular portion of drape hangs from the edge of
delivery table or it can be placed flat on the delivery table.
? A stiff wire holds the pouch open to collect all the blood.
? Funnel is calibrated with two lines namely yellow alert line at 350
ml mark, red action line at 500 ml mark for the diagnosis of PPH.
STRUCTURE
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Usage of Blood Collection Drape
Delivery of the Baby
?
Rectangular portion of drape is placed under buttocks
with the funnel portion lying on the table
?
Blood drape to be tied around woman at two places (Waist and Hip)
?
Thick, rolled towel/cloth is placed underneath women’s shoulder
(To facilitate downward flow of blood and to avoid pooling of blood under
her back)
?
Using gloved hand, sweep all blood in to the bag
?
Assess the blood loss by measuring the amount of blood collected in the
funnel
?
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Using both hands, grasp the opposite edges of the top of the funnel and
compare the amount of the blood loss in relation to the two lines (Alert
&Action)
?
No need to remove the drape to measure the blood loss
COLLECTION OF BLOOD
30
MEASUREMENT OF BLOOD LOSS
Cleaning and storage of drape
For reusing the drape, following three steps are to be followed.
1. Decontamination: By immersing in 0.05% bleach for 10 minutes.
2. Wash thoroughly with detergent & water and then air dry.
3. No need for sterilization as the drape is not going into the body.
4. After cleaning, the drape is folded and stored.
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POSTPARTUM HAEMORRHAGE
DEFINITION
Haemorrhage that occurs after delivery of the baby is termed as
postpartum haemorrhage. In quantitative terms it is defined as any blood
loss equal to or more than 500ml after vaginal delivery or 1000ml
following caesarean section or 10% fall in haematocrit when compared to
the pre labour values.
Even with accurate measurement, the amount of blood loss is often
less important than its effect on woman, which depends on her volume of
blood and other associated health factors ( eg - Hb % status ) . Hence it is
being suggested that any blood loss that leads to a major physiological
change like fall in blood pressure, is taken in to account23. Mortality due to
PPH is different from other obstetric causes because the time interval
between delivery to the death of mother is short.
After delivery of the fetus if a woman bleeds profusely and if no
treatment is given, then death will occur within 2 hours. In contrast, Ante
partum Haemorrhage will lead to death within12 hours, obstructed labour
within 2 days, if there is no intervention4.
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This difference is due to following two reasons:
1.Placenta normally occupies 20cm diameter area of the maternal
surface of uterus. If after delivery of placenta, the normal contractile
mechanism doesn’t come into play, then uterus continues to bleed from
that placental site.
2.Spiral and arcuate branches have a direct connection with aorta via
uterine, internal iliac and common iliac arteries.
AETIOLOGY AND RISK FACTORS
Aetiology:
PPH is usually due to abnormalities in any one of the following 4 basic
processes (referred as 4 Ts mnemonic)
1.Tone (inadequate uterine contraction)
2.Tissue (retained products of conception/ clots)
3.Trauma
4.Thrombin (abnormalities in the coagulation)
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RISK FACTORS (RCOG GREEN TOP GUIDELINE, no.52 May
2009/ Minor  revision 2011)5
Period Risk factors
Pre-conception Age more than 40, not multiparity
Asian ethnicity
BMI >35 kg/m2
During pregnancy Anaemia <9g/dl
 placenta previa
 placental abruption
Pre-eclampsia or gestational
hypertension
Induction of labour
During delivery Prolonged labour
Operative vaginal
delivery/caesarean section
Birth weight  >4 kg
 Episiotomy, Retained placenta
Pyrexia in labour
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However PPH can occur even in women without any risk factors
cited above. Numerically, atonic PPH can occur more in women without
risk factors than those with risk factors
Patho-physiology:
Blood vesssels supplying the placental bed pass through the
interlacing fibres of the myometrium. Myometrial contraction is the main
force for the separation of the placenta and constriction of the blood
vessels and this normal physiological phenomenon is known as living
ligatures/physiological sutures.
Bleeding occurs from the placental site of the uterus when the
placenta got separated. If there is failure of this normal living ligature
mechanism of myometrium, then it will lead to atonicity of the uterus.
Considerable blood loss can be tolerated by young and healthy
women for a longer period even without any cardiovascular changes.
Severe Haemorrhage causes shock, morbidity &death.
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Shock is divided into three divisions according to the amount of blood
volume lost.23
Degrees Amount Features
Mild 20% of blood volume Decreased perfusion of non-vital
organs.(skin, fat, muscle)
Pale, cool skin
Moderate 20-40% of blood
volume
Decreased perfusion of vital
organs (liver, kidney etc.).
Oliguria and or anuria.
Drop in BP.
Severe >40% of blood volume Decreased perfusion to heart,
brain.
Restlessness, agitation, coma,
ECG and EEG abnormalities.
Cardiac arrest.
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PREVENTION
Only 40% of women with PPH have identifiable risk factors24.
Prevention of PPH includes following factors20:
1. Antenatal risk assessment.
2. Developing birth preparedness.
3. Treatment of anaemia and other risk factors to withstand PPH
sufficiently.
4. Appropriate management of labour.
5. Harmful traditional practices (eg,pushing on uterus to expel baby) to
hasten delivery should be avoided.
6. Prevent dehydration.
7. Encourage passage of urine frequently.
8. Avoid pushing before full dilatation.
9. Early detection & quick management of haemorrhage.
10.Active Management of Third stage of Labour.
TREATMENT23
With the use of mnemonic HAEMOSTASIS, systematic and step-
wise management of PPH can be achieved. It is divided into two parts.
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General Medical Management:
H – Call for help.
         In case of major PPH, senior obstetrician and anaesthetist, theatre
staffs, blood bank staffs should be alerted.
A – Assess (vitals, blood loss) and resuscitate.
Vitals assessment –  level of consciousness, B.P, Pulse rate, urine
output, oxygen saturation.
        Estimation of blood loss is done by various methods.
Two large bore cannulae are inserted. Blood for cross matching,
Complete Blood Count, Renal Function Test, Liver Function Test is taken.
Initial  fluid Resuscitation - 1 litre of blood loss – needs replacement
with 4 to 5 litres of crystalloid (0.9% Normal saline/ ringer lactate) until
blood available.
Golden Hour:
It is the time at which prompt resuscitation should be commenced to
ensure the best chances of survival and if the patient is not efficiently
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resuscitated during this period, the probability of survival decreases
sharply.
For general acute management of PPH, “RULE of 30” is applied.
30% of blood volume loss is indicated if26
? Pulse rate increased by 30/min.
? Respiratory rate more than 30 /min.
? Systolic BP decreases by 30mmHg.
? Urine output < 30ml/hour.
? Haematocrit drops > 30%.
Shock index27:
? It is calculated by pulse rate / systolic B.P.
? The normal value is 0.5 – 0.7.
? If it is > 0.9, it indicates shock that needs urgent resuscitation.
Establish aetiology by
1. Examining the tone of the uterus.
2. Excluding trauma / retained products of conception.
3. Bleeding Time, Clotting time monitoring.
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Ecbolics:
 As atonic PPH is the most common cause, medical management of
atonic PPH consists of
1. Oxytocin 10 units slow intravenously
2. Methergine 0.2 mg i.m/i.v
3. Oxytocin infusion
4. 15-methyl PGF2? (carboprost) i.m
5. Rectal misoprostol
Blood & Blood products transfusion needed if
1. Continuous bleeding
2. >30% of blood volume loss
3. Despite resuscitation, haemodynamically unstable
 M – Massage the uterus. Either manually with keeping hand on the fundus
of uterus or bimanually with one hand kept in the anterior fornix of vagina
and another hand kept on the posterior aspect of the uterus.
It is a very simple and effective method to reduce the bleeding if the
uterus remains atonic.
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O – Oxytocin infusion, Prostaglandins.
In order to maintain the contraction of the uterus, oxytocin can be given
slow intravenously or as an infusion (40 units in 500 ml of 0.9% normal
saline at the rate of 125 ml per hour).
If the uterus remains atonic even after oxytocin, ergometrine should
be given.
Carboprost (PGF2?) one ampoule can be given intra muscularly, as a
second line of drug if atonicity persists, as it is highly effective (80 – 90%)
in cases refractory to oxytocin and ergometrine.
Misoprostol (PGE1 analogue) has been used for the management of
PPH. In a placebo randomised controlled trial (BJOG 2004:111:1014-
1017) it was shown that misoprostol was not associated with any decrease
in maternal mortality, blood transfusion, additional use of other uterotonics
& it was associated with increased rate of pyrexia & shivering.
However, another unblinded trail conducted by Lokugamage34 AU,
Sullivan KR, Niculescu I et al, showed better clinical response with
misoprostol (rectal) than with combination of syntometrine and oxytocin.
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SURGICAL MANAGEMENT: (STASIS)
S- Shift the patient to the operation theatre. Anti-shock garment to be
applied especially if transfer is required.
T- Successful use of uterine balloon tamponade was reported using
number of various devices like Foley’s catheter, a condom, Sengstaken –
Blakemore oesophageal catheter.
A-Application of compression sutures like B-Lynch or Modified B-Lynch
if bleeding persists.
S- Systematic pelvic devascularisation to be done as the next step if
bleeding persists wherein uterine, ovarian and internal iliac arteries are
ligated.
I- Interventional radiology. Arterial embolisation was first described in
1979. Success rate may be as high as 70 – 100% and it preserves fertility.
But the need of specialised equipment and expert radiologists are its
limitations.
S- Subtotal or total hysterectomy is the final option and it should not be
delayed if other measures are futile.
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MATERIALS AND METHODS
1, Type & place of study.
It is a randomised clinical controlled trial on 400 pregnant women
 admitted to labour ward at R.S.R.M. Lying in Hospital, Stanley medical
 college ,Chennai.
2, Duration of the study:
          January 2013- December 2013.
3, Inclusion criteria:
a. Primi / mutigravida (upto third gravida)
b. Age group between 18-35 years.
c. Term, singleton, alive pregnancy.
d. Vertex presentation with adequate liquor.
e. Average size foetus (E.F. Wt 2-4kg)
f. Expected to have spontaneous delivery.
    (Augmentation with oxytocin included)
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4, Exclusion criteria:
a. Anaemia / preeclampsia / coagulation disorder complicating pregnancy.
b. Overdistended uterus (hydromnios / multiple pregnancy / large baby).
c. Antepartum haemorrhage.
d. Induced labour.
e. Instrumental delivery.
f. Previous LSCS.
g. Premature rupture of membrane.
h.Retained Placenta.
PROCEDURE
? Detailed history was taken from all women.
? General and obstetric examinations were done in all cases.
? Gestational age was confirmed by menstrual history,
ultrasonogram, and abdominal examination.
? Routine urine and haematological examination were done.
? Vitals, uterine contraction, foetal heart rate and progress of labour
were monitored carefully using partogram.
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? Labour was augmented with oxytocin in active phase of labour.
? All women in the study group were explained in detail about the
procedure of cord blood drainage and informed consent was
obtained.
5, TYPES OF INTERVENTION:
                                      400 pregnant women (randomly allocated into)
Study group 200                                                       control group 200
Placental end of the previously clamped and cut           placental end of the
umbilical cord  was unclamped immediately                 umbilical cord
and it was left open to drain the blood until                   remain  clamped.
 the flow ceased and this blood was collected in a
separate kidney tray.
Blood collection Drape was applied in both groups after delivery of the
baby. Placenta was delivered by controlled cord traction in both groups.
Injection oxytocin 10 units i.m. was given after delivery of foetus in both
groups. As soon as the placenta delivered, it was examined thoroughly to
find out any missing cotyledons or membranes.
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All women in both groups were examined carefully, for tears in cervix
vagina, perineum or  para urethral area.
Episiotomy was sutured in layers, if it was given.
Women in both groups were observed & vitals monitored for two hours.
Every 15 minutes, uterus was palpated and assured that the uterus
contracted well.
6. TYPES OF OUTCOME  MEASURED
a. Duration of third stage of labour:
Third stage of labour begins after delivery of foetus and it involves
separation and expulsion of placenta with its entire membranes.
It was calculated using a stopwatch.
b. Measurement of blood loss:
Visual estimation of blood loss always has  inaccuracies. In our
study, blood loss was measured using a drape.
Mops used for episiotomy suturing were discarded.
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7. OTHER OUTCOME MEASURES
1.Occurence of postpartum haemorrhage
2.Need for blood transfusion
3.Haemoglobin difference between antenatal and post natal period
(48 hours after delivery).
Postpartum haemorrhage (PPH):
 Those women who had blood loss ? 500ml following delivery of
foetus was noted & management of PPH was done.
Minor PPH:
Blood loss between 500- 1000ml and it is not associated with any
signs and symptoms of shock.
Major PPH:
Blood loss more than 1000ml and is associated with continuous
bleeding / signs of shock.
Blood transfusion was given depending on the clinical degree of
anaemia and the haemoglobin status of women.
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Repeat haemoglobin was done in all women of both groups, 2 days
postnatally. Haemoglobin difference between antenatal and postnatal
period was calculated and compared between study and control groups.
   After collecting all data, it was tabulated in a master chart. The
results were analysed using the Stastistical Package for Social Science
(SPSS) version 11.5.
The results were expressed as frequency, mean ± standard
deviation, median. Statistical comparision was done using Chi square test /
independent t test / paired t test.
Two tailed P value was calculated.P value < 0.05 is considered as
significant & if the value is < 0.001 it is considered as highly significant.
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RESULTS
PROFILE OF STUDIED CASES
Table – 1        Age Distribution
AGE
(in yrs)
CONTROL STUDY
No % No %
18 – 20 15 7.5 18 9
21 – 25 139 69.5 119 59.5
26 – 30 36 18 54 27
31 – 35 10 5 9 4.5
Total 200 100 200 100
Mean 23.47 24.18
S.D 3.07 3.07
P Value 0.14
Age of selected women, varies between 18-35yrs. While comparing
the age group between the study and control groups, 7.5% of control and
9% of study group were between 18-20yrs; 69.5% of control and 59.5% of
study group are in the age group of 21-25 yrs; 18% of control, and 27% of
study group are in the age group of 26-30 yrs; 5% of control, and 4.5% of
study group were in the age group of 31-35 yrs.
Mean age of control group was 23.47 &study group was
24.18.Using Pearson – Chi Square test, P Value was calculated. P value is
0.140 which is not significant.
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Table – 2
ANTENATAL CARE
ANTENATAL
CARE
CONTROL STUDY
No % No %
Booked 192 96 194 97
Un booked 8 4 6 3
Total 200 100 200 100
P Value 0.58
Those who had at least 5 antenatal visits, not only in our hospital but
also at outside are considered as booked cases. 96% of control group and
97% of study group were booked cases.
        There is no significant variance between control and study groups. P
Value calculated using Pearson chi square test. P Value is 0.58 which is
not significant.
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Table – 3
OBSTETRIC FORMULA
OBSTETRIC
FORMULA
CONTROL STUDY
No % No %
Primigravida 103 51.5 121 60.5
Multigravida
 (Up to G3)
97 48.5 79 39.5
Total 200 100 200 100
P Value 0.070
While comparing obstetric formula between control and study
groups, 51.5% of control group and 60.5% of study group were
primigravida. 48.5% of control and 39.5% of study group were
multigravida. P value calculated using pearson chi-square test. P value was
0.070 which is not significant.
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Table -4
QUANTITATIVE PARAMETERS
PARAMETERS
CONTROL STUDY
P VALUEMEAN S.D MEAN S.D
Height(cm) 154.3 0.051 154.5 0.04 0.688
Weight(kg) 59.21 6.9 59.15 6.5 0.929
BMI 24.85 2.72 24.77 2.60 0.743
BMI ?Body mass Index
S.D? Standard deviation
Quantitative parameters like height, weight and BMI were
calculated & compared between control and study groups. Mean height
was 154.3 cm in control group and 154.5 cm in the study group. Mean
weight was 59.21 kg in control group and 59.15 kg in study group. Body
mass index calculated by weight / height (in m2). Mean value of BMI in
control group was 24.85 and 24.77 in study group.
P value was calculated by using t test and as shown in table there
was no significant difference between control and study group regarding
height, weight and BMI.
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Table – 5
GESTATIONAL AGE
GESTATIONAL AGE
(in wks)
MEAN S.D
Control 38.22 0.58
Study 38.31 0.61
P Value 0.126
           S.D-Standard Deviation.
Those who have completed  37 gestational weeks were included in
the study. Those who have crossed 40 weeks were excluded from the
study. Mean gestational age in the control group was 38.2 and in the study
group was 38.31.
P value was calculated using t test .P value was 0.126 which is not
significant.
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TABLE – 6
AUGMENTATION OF LABOUR WITH OXYTOCIN
OXYTOCIN
ACCELERATION
CONTROL GROUP
No % No %
Yes 181 90.5 184 92
No 19 9.5 16 8
Total 200 100 200 100
P Value 0.596
Labour was augmented with oxytocin drip, in active phase of labour
in both groups.
Almost 90.5% of control group and 92% of study group were
augmented with oxytocin.
P Value was calculated using  Pearson chi-square test. P value was
0.596 which is not significant.
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TABLE – 7
DURATION OF STAGES OF LABOUR
DURATION
OF STAGES
OF LABOUR
CONTROL STUDY P
VALUE
No Mean S.D S.E of
mean
No Mean S.D S.E of
mean
I (in hrs) 200 8.13 2.72 0.192 200 8.17 2.66 0.188 0.85
II (in mnts) 200 26.60 9.025 0.638 200 25.69 8.11 0.574 0.29
III (in mnts) 200 5.06 1.38 0.097 200 3.56 1.32 0.093 <0.001
S.D-Standard Deviation
S.E-Standard Error
Since prolonged labour precipitates postpartum haemorrhage,
duration of stages of labour was compared between study and control
groups.
Mean duration of first stage is 8.13 hrs in control group and 8.17 hrs
in study group. P value was calculated by t test which was 0.85, that is not
significant.
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Mean duration of second stage of labour in control group was 26.60
minutes. Standard deviation was 9.02. Mean duration in study group was
25.69 minutes. Standard deviation was 8.11. P value (calculated by t test)
was 0.29, that is not significant.
Mean duration of third stage of labour in control group was 303.6
seconds ( 5.06 minutes) &in study group  was 214 seconds (3.5 minutes).
P Value was < 0.001(t test) which is highly significant.
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Table – 8
MODE OF DELIVERY
MODE OF DELIVERY CONTROL STUDY
No % No %
Labour Natural with
Episiotomy
183 91.5 178 89
Labour Natural with LP 8 4 7 3.5
Labour Natural 9 4.5 15 7.5
Total 200 100 200 100
P Value 0.441
LP? Perineal Laceration
Mode of delivery was compared between control and study groups.
Preliminary mediolateral episiotomy was given after crowning of head in
91.5% of control group and 89% of study group. Perineal laceration
occurred in 4% of control group and 3.5% of study group. 4.5% in the
control group and 7.5% in study group were delivered by labour natural.
P Value calculated by Pearson chi-square test. P value was 0.441
which is not significant.
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TABLE – 9
BLOOD LOSS DURING STAGE III OF LABOUR
BLOOD LOSS
DURING III STAGE
(in ml)
CONTROL STUDY
No % No %
? 100 ml 10 5 30 15
101 – 200 40 20 92 46
201 – 300 84 42 54 27
301 – 400 42 21 16 8
401 – 499 7 3.5 4 2
? 500 17 8.5 4 2
Total 200 100 200 100
Mean 308.95 185.58
S.D 173.86 110.09
P Value 0.001
Blood loss during third stage of labour was measured using a
calibrated drape. Mops used for episiotomy wound were discarded.
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         5% in control group and 15% in study group had blood loss < 100
ml. 20% in control group and 46% in study group had blood loss between
101-200 ml. 42% in control group and 27% in study group had blood loss
between 201-300 ml. 21% in control group and 8% in study group had
blood loss between 301-400 ml. 3.5% in control group and 2% in study
group had blood loss between 401-500 ml. 8.5%  in control group and 2%
in study group had blood loss more than 500 ml.
Mean blood loss in study group was 185 ml and  in control group
was 308 ml .Difference between two groups was 123 ml.None of the cases
in both groups had blood loss > 1000ml.
P value was calculated by using Pearson chi-square test which was
<0.001 that is highly significant.
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Table – 10
BIRTH WEIGHT
GROUP
BIRTH WEIGHT (in kg)
No Mean S.D S.E of Mean
Control 200 2.84 0.387 0.027
Study 200 2.87 0.388 0.027
P Value 0.414
 S.D-Standard Deviation, S.E-Standard Error.
Birth weight of the baby was calculated using standard weighing
machine.
  Average birth weight in control group was 2.84 kg and in study
group was 2.87 kg. Standard deviation and P value were calculated using t
test. P Value was 0.414 which is not significant.
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TABLE – 11
OCCURRENCE OF POSTPARTUM HAEMORRHAGE (PPH)
OCCURRENCE OF PPH CONTROL STUDY
No % No %
Yes 17 8.5 4 2
No 183 91.5 196 98
Total 200 100 200 100
P Value 0.004
8.5% of control group & 2% of study group had blood loss ? 500
ml. None of both groups had more than 1000 ml of blood loss.
 P value was calculated using Pearson chi-square test. P value was
0.004. Hence the difference between control and study group is significant.
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TABLE 12
NEED FOR BLOOD TRANSFUSION
NEED FOR
BLOOD
TRANSFUSION
  CONTROL STUDY
NO % NO %
Yes 15 7.5 4 2
No 185 92.5 196 95.3
Total 200 100 200 100
P Value 0.010
 7.5% in control group & 2% in study group needed blood
transfusion.
 P Value was calculated using Pearson Chi-square test, which was
0.010 , that is significant.
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TABLE – 13
HAEMOGLOBIN (Hb%) DIFFERENCE BEFORE AND AFTER
DELIVERY
Hb% DIFFERENCE
(in gms)
CONTROL STUDY
Mean 0.68 0.28
S.D 0.3 0.15
S.E of Mean 0.02 0.011
P Value < 0.001**
** ? highly significant
S.D ? Standard Deviation
S.E? Standard Error
Haemoglobin % was estimated in all  cases antenataly and repeat
Hb% was seen in all  cases 48 hrs after delivery. Haemoglobin difference
before and after delivery was calculated in both control and study groups.
The mean difference in Hb% in control group was 0.68. In study group it
was 0.28.
P Value  was calculated using t  test.  P value was < 0.001 and it  is
highly significant.
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DISCUSSION
Even with in very few minutes, normal progression of labour can
become abnormal or a successful delivery can turn into a disaster if post
partum haemorrhage occurs.
Hence appropriate management of third stage of labour and prompt
recognition of its complications should be done or otherwise it may end up
in maternal death.
This study was conducted at R.S.R.M lying in Hospital, Stanley
Medical College, Chennai to study the efficacy of Placental Cord Blood
drainage versus none as a part of management of third stage of labour after
vaginal delivery.
In this study placental cord blood was drained by unclamping the
previously clamped and cut cord in 200 vaginal deliveries and in another
200 vaginal deliveries, the cord was remain clamped and it was not
drained.
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Discussion of profile of studied cases
Age Group:
In our study, pregnant women between 18 – 35 yrs were included in
the study .Majority of pregnant women belonged to the age group of 21 –
25 yrs.
Around 88% of control group & 87% of study group of women were
between 21 – 30 yrs. Mean age in control group is 23.4 yrs, & in study
group is 24.18.  Both groups (Control and study) are comparable regarding
the age group. ‘P’ Value calculated & it is also not significant.
In a similar randomized controlled trail of placental cord blood
drainage conducted in Department of Obstetrics and Gynaecology at J.N.
Medical College, Belgaum, 2007 for the prevention of post partum
haemorrhage, mean age of both groups were between 23-24 yrs.
In another similar study, conducted by Melal Mohammed, at
Babylon University, 2010, mean age of both groups,varied between 26-
27yrs.
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Antenatal Care:
Those women,who had atleast 5 antenatal visits,not only in our
hospital but also outside were considered as booked cases. In our study,
the proportion of antenatal mothers who were booked was greater than
those who did not, in both groups. 96% of control group and 97% of study
group were booked, and there was no significant difference between
control and study groups in terms of antenatal care.
Obstetric formula:
In our study there were more primigravida in both control and study
groups, when compared with multi gravida. Multi gravida – upto third
gravida were included.
In the control group
 -Around 52% were primigravida and 48% were multi gravida
In the study group:
 - Around 61% were primigravida and 39% were multi gravida.
Hence parity was comparable in both control and study groups.
     In a similar study, by Shravage et al, both groups were comparable
in terms of gravidity & parity.
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Period of gestation:
In our study pregnant women between 37 to 40 completed weeks
were included in the study. Preterm labour was excluded from the study.
 All were singleton, viable pregnancies.
The mean gestational age was 38.2 weeks in control group and 38.3
weeks in study group. Hence it was comparable in both groups.
In a similar randomized controlled trial by Shravage JC and Silpa,
(Journal of Obstetrics and Gynaecology of India, Article, 2007)  mean
gestational age was 38.7 weeks in study group and 38.5 weeks in control
group.
In another study by Sharma et al, mean age group varied between
38.5-38.7 in both groups.
Quantitative Parameters:
In our study, in terms of height, weight and body mass index, both
control and study groups were comparable.
         Those with blood pressure ? 140/90 mm of Hg were excluded.
        Routine urine and blood examination was normal in both control and
study groups. Previous studies also showed the same result.
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Augmentation of Labour:
 400 pregnant women with spontaneous onset of labour were
included for the study. Induction of labour either by cerviprime gel, (or)
stripping was excluded from the study.
Progress of labour was monitored using partogram. Labour was
augmented with oxytocin  in active phase of labour.  Majority of women in
both control and study groups were augmented with oxytocin.
 In our study, around 91% in control group and 92% in study group
were augmented with oxytocin  and both groups were comparable in terms
of oxytocin acceleration.
In a similar study by Hora Soltani 2011,both groups were
comparable in terms of augmentation of labour.
In another study by MelalMohammed at Babylon, augmentation
with oxytocin was comparable in both groups.
Duration of Labour: (I and II Stage)
As prolonged labour precipitates post partum haemorrhage, duration
of first and second stages was compared in both groups. Duration of first
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stage, calculated from onset of true labour pains up to full dilatation of
cervix.
          Mean duration of first stage was 8.13 hrs in control group and 8.17
hrs in study group, which was comparable and the ‘P’ Value was not
significant.
         Second stage of labour calculated from full dilatation of cervix up to
delivery of  foetus. Mean duration of second stage was 26.60 minutes in
control group and 25.69 minutes in study group which was also
comparable and the P Value was not significant.
In a similar study by Shravage JC in 200 pregnant women , mean duration
of I stage of labour in control group was 9.6 hrs & in study group was
10.17 hrs,  II stage of labour in control group was 22.05 mnts & in study
group was 24.15 mnts. Both stages (I & II) were comparable between 2
groups.
Mode of Delivery:
As labour natural with episiotomy may augment the blood loss
during third stage of labour both control and study groups were compared
in terms of mode of delivery. Major proportion of women in both control
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and study groups were given mediolateral episiotomy after crowning of
head.
Around 92% of women in control group and 89% of study group
were delivered by labour natural with episiotomy, around 9% of control
group and 8% of study group were delivered by labour natural . 4% of
control and 3.5% of study group were delivered by labour natural with
perineal laceration.
In a similar study by Soltani 2011, mode of delivery was
comparable.
Birth weight:
Birth weight  between 2 – 4 kg were taken for the study. Mean birth
weight was 2.84 kg in control group and 2.87 kg in study group & hence it
was comparable. P Value was not significant.
This was similar to a study done by Sharma et al 2008. The mean
birth weight was 2.9 kg in study and 2.8 kg in control group.
70
OUTCOME PARAMETERS:
Duration of III stage of labour:
In our study the duration of III stage of labour from the delivery of
the baby up to the delivery and expulsion of placenta with its entire
membranes was calculated using stop watch .
The mean duration of IIIrd stage of labour was 5.06 minutes (303.6
seconds) in control group and in study group it was 3.5 minutes (214
seconds) and the difference was 1.5 minutes & the result was statistically
highly significant (P value is <0.001).
Several studies had similar reports.  Gulati et al showed that, in a
study of 200 pregnant women, mean duration was 2.9 minutes in study
group and 5.72 minutes in control group.
         In a similar study conducted by Soltan H, Poulose TA, Hutchon DR,
2011, published in Cochrane review, in 1257 women, cord blood drainage
reduced the duration of third stage by a mean of 3 minutes,and the same
was shown in French cochrane review, 2012. In another Cochrane review
2009, study conducted by Hora Sotani, Fiona Dickinson, Ian M Symonds,
the mean difference was 5.4 minutes.
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 In another study by Melal at Babylon University, 2010, mean
duration was 5.3 mnts in study group & 8.9 mnts in control group.
In a study at Bangkok, Thailand, 2009, mean duration was 5 minutes
in study group and 7 minutes in control group.
In another study conducted by Sharavage, J.N. Medical College,
Belguam mean duration of third stage of labour in study group was 5
minutes and in  control group was 7.4 minutes.
In a study by Giaclaone et al 2000, involving 500 patients, the mean
value in control group was 15 minutes and 8 minutes in study group.
Blood Loss during third stage:
In our study, cord blood was drained and collected in a separate
clean kidney tray and the blood loss during third stage was measured using
a calibrated blood collection drape. Great effect was taken to measure the
blood loss accurately and separate mops were used for episiotomy wound
suturing.    But the limitation of our study is some amount of inclusion of
amnion fluid and omission of some amount of blood, spattered on to the
gowns (or) delivery table. This could affect the blood loss measurement.
However the likely error would be random and reduce the power, but not
bias the result of the study.
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Another major confounding factor in such studies could be the
variation in the use of oxytocic drugs both in relation to the time of
administration and the type of drug used. It could have a significant effect
on the duration of 3rd stage of labour. But it was avoided in our study by
giving injection oxytocin 10 units intramuscularly within 1 minute of
delivery of foetus as part of active management of third stage of labour, in
all cases. Similarly the timing of umbilical cord clamping may confound
the result. In our study, fortunately in all cases both in control and study
groups, the umbilical cord was clamped immediately or within 30 seconds
after delivery.
In our study, mean blood loss was 308 ml in control group and
185ml in study group.Hence cord blood drainage reduced the blood loss by
123 ml.
‘P’ Value was < 0.001 which is highly significant.
In a similar study conducted by Soltani H, Poulose TA, Hutchon
DR, 2011& French Cochrane review 2012 cord blood drainage reduced the
blood loss during third stage by average of 77 ml.
 In another study by Melal, 2010, it was 184 ml in study group &
249 ml in control group.
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Shravage et al showed that average blood loss was 252 ml in control
and 175 ml in study group.
         Gulati et al reported that the amount of blood loss was 247 ml in
control group and 193 ml in study group.
Post Partum Haemorrhage and Need for Blood transfusion
As per the standard definition of postpartum haemorrhage, it was
calculated that any blood loss of equal to or more than 500 ml was
considered as postpartum Haemorrhage .In our study 8.5% in  control
group and 2% in study group had blood loss more than 500 ml. None of
both groups had blood loss > 1000 ml. Among the control group 7.5%  &
2% of study group needed blood transfusion .Repeat blood transfusion was
planned if repeat Hb% was  < 8gms / dl. None of the cases either in control
or in study group needed more than 2 blood transfusions. Only two
patients in the control group needed two blood transfusions.
 In those patients who had postpartum haemorrhage, it was managed
with general measures & medical management (40 units of oxytocin added
in saline drip / inj. Carboprost ( 15 –methyl PGF2?) one ampoule  i.m / inj.
Methergine 2 ampoules i.v/ rectal misoprostol 800 µg kept rectally) and
blood transfusion.
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2 Cases in the study group and 10 cases in the control group were
given inj. Carboprost (15 – methyl PGF2?) l ampoule i.m and rectal
misoprostol 800 µg kept in addition to oxytocin. None of the cases either
in control or in the study group needed surgical management of PPH.
 In our study the incidence of post partum Haemorrhage in the
control was 8.5% and in the study group it was 2%. P Value was 0.004
which is significant.
           In a similar study by sharavage et al, J.N. Medical College,
Belgaum the incidence was 3% in the study and 10% in the control groups.
Gulati et al studied 200 women and reported that incidence of PPH
was 6% in study group and 12% in the control group
In a study by Soltani, 2011, there was no significant difference
noted between both groups, regarding the rate of PPH/Blood transfusion.
In another study involving 200 women, by Melal Mohammed, 2010,
none of the study group had PPH/ needed blood transfusion & only one in
control group had PPH and needed blood transfusion..
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Hb% difference between antenatal and post natal period
Routine Hb% measurement was done in all cases of study and
control group. Repeat hemoglobin (Hb %) was done 48 hours after
delivery. Difference between antenatal and post natal values were
calculated in both study and control groups.
         Mean difference in control group was 0.68 gms and in the study
group was 0.28 gms. The difference between the control and study group
was statistically highly significant as shown by the P Value which is <
0.001.
In a similar study by Melal Mohammed 2010 in 200 women and another
study by Giaclone  in 200 women , the difference in Hb%  (before & 2
days postnatal) was more in control group than in study group & the result
was significant.
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SUMMARY
 Placental cord blood drainage after vaginal delivery as a part of
management of third stage of labour is a randomized clinical controlled
trail on 400 pregnant women admitted to the labour ward at R.S.R.M.
lying in Hospital, Stanley Medical College between Jan 2013 – Dec 2013.
Those who met the inclusion criteria were selected for the study.
They were allocated in two groups as 200 pregnant women in one
group as control and 200 another pregnant women in study group.
In both groups, detailed general &obstetric examinations were done.
Progression of labour was monitored carefully.  Duration of all stages of
labour (I, II, and III) noted in all cases.
In the study group after delivery of the foetus, previously clamped
and cut umbilical cord was unclamped immediately and the placental
blood was drained in a separate kidney tray, while the umbilical cord
remained clamped in the control group. Inj. Oxytocin 10 units  i.m given
as a part of active management of third stage of labour in all cases within 1
minute after delivery.
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Amount of blood loss during 3rd stage, occurrence of postpartum
haemorrhage, need for blood transfusion and  Hb% difference were noted
in both groups.
The results were tabulated and summarized as follows:-
1. Majority of cases in both groups were between 21 to 30 yrs.
2. Major proportion of cases (96 – 97%) were booked and immunized
in both groups.
3. 50% of control group and 60% of study group were constituted by
primigravida and the rest were multigravida (up to G3).
4. The mean gestational age in both control and study groups were
similar & it was around 38 weeks.
5. Height, weight and body mass index were comparable in both study
and control groups.
6. Around 90% in both control and study groups, augmentation with
oxytocin drip during active phase of labour was done.
7. Duration of first and second stages were comparable in both study
and control groups.
8. Mode of delivery (either labour natural with episiotomy / labour
natural with LP/labour natural) was also comparable between study
and control groups.
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9. Mean birth weight of babies were comparable in both groups it was
around 2.9kg in study group and 2.8 kg in control group.
10. Mean duration of III stage of labour was 5.06 minutes in control
group and 3.5 minutes in study group and the difference is highly
significant statistically.
11. Mean blood loss during III stage of labour was 308 ml in control
and185 ml in study group and the difference is highly significant.
12. Incidence of  Post Partum Haemorrhage was 8.5% in control group
and 2% in study group and none of the cases required surgical
management of PPH.
13. 7.5% of cases in control group and 2% of study group needed blood
transfusion after delivery.
14. Analysing the Hb% difference between antenatal and postnatal
period (Repeat Hb% 2 days after delivery) in both groups, it was
0.68 in control group and 0.28 in study group which was highly
significant.
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CONCLUSION
1. Placental cord blood drainage reduces the duration of third stage of
labour.
2. It reduces the blood loss during third stage of labour.
3. Incidence of Post Partum Haemorrhage is reduced in cord blood
drainage group and the need for blood transfusion after delivery is
also decreased in placental blood drainage group.
4. The decrease in Hb% after delivery is less with the placental blood
drainage group.
5. Placental blood drainage does not need any extra cost, equipment
(or) effort and it is a simple, non invasive safe method that can be
practiced even by midwives in rural settings as a part of
management of third stage of labour in reducing the blood loss
during third stage.
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ABBREVIATIONS
PPH-Postpartum Haemorrhage.
LN with LP – Labour natural with perineal laceration
AMTSL - Active management of Third stage of labour
BJOG -     British Journal of Obstetrics & Gynaecology
RCOG - Royal College of Obstetrics & Gynaecology
O & G - Obstetrics & Gynaecology
WHO -   World Health Organisation
FIGO -   International Federation of Obstetrics & Gynaecology
B.P.    -   Blood Pressure
P.R.    -   Pulse Rate
PGE   -   Prostaglandin E
PGF2? – Prostaglandin F2?
 i.m.    -       Intramuscular
inj      -       injection
i.v.      -      Intravenously
Hb     -       Haemoglobin
gms -        Grams
G3P2 L2- Gravida 3 Para2 Live2
yrs      - years
mnts- Minutes.
Hrs-Hours
RL/ NS – Ringer lactate / Normal saline
BMI-Body Mass Index.
ECG-Electro cardio gram.
E.F.Wt-Estimated Foetal Weight.
S.D-Standard Deviation.
S.E-Standard Error.
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PER ABDOMINAL EXAMINATION:
PER VAGINAL EXAMINATION:
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                             Labour Natural                     Without Epi
                                                                                 LP
TIME OF
ADMISSION IN
LABOUR WARD
DURATION OF STAGES OF LABOUR
I (in Hours) II (in Mnts) III (in Sec)
OXYTOCIN
ACCELERATION
BLOOD
LOSS
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STAGE (in
ml)
OCCURENACE
OF PPH
NEED FOR
BLOOD
TRANSFUSION
Baby: Term/Preterm
            Birth weight
Rpt Hb: ( 48 hours postnatal)
INVESTIGATIONS:
Urine: Hb% Blood Sugar
Albumin PCV HIV
Sugar Platelet Count VDRL
Deposits BT
CT
Blood group & Type
ULTRASONOGRAM:
REMARKS:
Booked / HEIGHT WEIGHT G.Age Oxytocin Mode OF Blood Loss Need for Occurence Birth
Un Booked (mt) (kg) (weeks) Accleration I Stage II Stage III Stage Delivery During Blood Of Weight AN PN
(Mnts) (Mnts) (seconds) III Stage (ml) Transfusion PPH (kg)
1 Durgadevi S 21 13780 B Primi 1.53 62 26.49 38.4 YES 690 35 140 LN with Epi 130 NO NO 3.50 11.0 10.8
2 Kalpana C 26 13686 B Primi 1.52 60 25.97 38.1 YES 600 45 420 LN with Epi 120 NO NO 2.70 10.2 9.4
3 Narmadha S 25 13780 B G2P1L1 1.47 60 27.77 38.4 YES 300 30 130 LN with Epi 210 NO NO 2.80 10.4 10.2
4 Priya C 27 13245 B G3P2L2 1.51 49 21.49 38.2 YES 330 25 300 LN with Epi 250 NO NO 2.25 9.6 9.0
5 Sindhu S 20 13724 B Primi 1.58 50 20.03 37.4 YES 570 25 360 LN with Epi 150 NO NO 3.00 9.8 9.6
6 Devi C 20 13200 B Primi 1.51 59 25.88 38.8 YES 445 32 320 LN with Epi 280 NO NO 2.90 9.8 9.0
7 Gayathri S 22 13734 B Primi 1.47 48 22.21 38.6 YES 565 30 220 LN with Epi 220 NO NO 3.20 9.8 9.6
8 Jamuna Devi C 22 16541 B Primi 1.59 64 25.32 38.6 YES 640 25 340 LN 270 NO NO 3.20 10.9 10.2
9 Sakila Banu S 23 13278 B G2P1L1 1.55 59 24.56 38.1 YES 335 15 240 LN with Epi 160 NO NO 2.10 9.8 9.6
10 Nandhini C 21 12895 B G2P1L1 1.53 56 23.92 37.6 YES 290 25 290 LN with Epi 130 NO NO 2.80 9.8 9.2
11 Petchaimmal S 26 13313 B G2P1L1 1.58 65 26.04 38.5 YES 355 12 180 LN with Epi 80 NO NO 2.10 10.8 10.6
12 Malathi C 22 126020 B G2P1L1 1.52 65 28.13 38.6 YES 340 15 280 LN with Epi 280 NO NO 2.20 10.2 9.4
13 Ambika S 24 13472 B G2P1L1 1.45 50 23.78 38.2 NO 280 12 180 LN with Epi 75 NO NO 3.20 9.8 9.4
14 Aswini C 22 13718 B G2P1L1 1.52 50 21.64 38.3 YES 345 20 380 LN with Epi 240 NO NO 2.40 9.8 9.0
15 Swetha S 20 13039 B G2P1L1 1.55 42 17.48 38.2 YES 295 15 240 LN with Epi 230 NO NO 2.50 9.8 9.6
16 Praveena C 24 11366 B Primi 1.48 55 25.11 38.6 NO 650 35 480 LN with Epi 280 NO NO 3.10 10.4 9.8
17 Bharathi S 28 13540 B G2P1L1 1.53 57 24.35 38.1 YES 350 20 260 LN 150 NO NO 2.50 10.2 10.0
18 Sasikala C 22 13041 B G2P1L1 1.52 68 29.43 37.6 YES 340 24 440 LN with Epi 270 NO NO 2.70 10.0 9.2
19 Usha S 20 13244 B Primi 1.70 64 22.15 38.4 YES 585 34 300 LN with Epi 205 NO NO 2.40 9.8 9.4
20 Anish Fathima C 22 11330 B Primi 1.58 60 24.03 38.2 YES 520 45 480 LN with Epi 220 NO NO 3.30 10.1 9.2
21 Sangeetha S 20 13225 B G2P1L1 1.52 64 27.70 37.4 YES 280 16 120 LN with Epi 145 NO NO 2.70 9.8 9.5
22 Vedhavalli C 23 12465 B G2P1L1 1.55 54 22.48 38.2 YES 300 18 240 LN with Epi 100 NO NO 2.40 10.3 9.4
23 Anusha S 24 13250 B G2P1L1 1.53 62 26.49 38.4 YES 280 17 240 LN with Epi 210 NO NO 2.70 9.8 9.6
24 Lakshmui C 24 12032 B G2P1L1 1.53 50 21.36 37.6 YES 320 25 320 LN with Epi 290 NO NO 2.70 10.2 9.6
25 Gayathri S 21 13264 B Primi 1.60 60 23.44 38.3 YES 645 27 120 LN with Epi 150 NO NO 2.50 10.8 10.6
26 Kalpana C 21 11754 B Primi 1.65 63 23.14 38.6 YES 620 45 260 LN with Epi 280 NO NO 2.50 10.4 9.8
27 Bakyalakshmi S 27 12491 B G3P2L2 1.54 59 24.88 38.2 YES 280 23 280 LN with Epi 220 NO NO 3.00 10.2 10.0
28 Nsreen Bnu C 23 11884 B G2P1L1 1.54 60 25.30 37.2 YES 360 15 220 LN with Epi 140 NO NO 3.10 9.8 9.6
29 Gulsam S 22 13166 B G2P1L1 1.55 59 24.56 38.5 YES 240 18 240 LN with Epi 170 NO NO 3.70 9.8 9.2
30 kala C 32 13733 B G3P2L2 1.60 65 25.39 38.1 YES 455 20 340 LN with Epi 270 NO NO 2.70 9.8 9.2
31 Aruna S 25 12187 B G2P1L1 1.50 70 31.11 38.4 YES 325 16 80 LN with Epi 120 NO NO 2.60 9.8 9.6
32 Lakshmi C 21 13323 B G2P1L1 1.44 48 23.15 38.1 YES 360 22 300 LN 285 NO NO 3.80 9.8 9.4
33 Amala S 27 11480 B Primi 1.55 63 26.22 38.4 YES 580 25 120 LN with Epi 75 NO NO 3.10 10.0 9.8
34 Latha C 24 11701 B Primi 1.64 62 23.05 38.8 YES 640 54 140 LN with Epi 290 NO NO 2.60 10.2 9.8
35 Renuka S 26 11423 B G2P1L1 1.60 65 25.39 38.4 YES 330 24 380 LN with Epi 210 NO NO 2.50 10.2 10.0
36 Nalini C 27 13273 B G2P1L1 1.60 66 25.78 38.6 YES 345 25 300 LN with Epi 270 NO NO 3.00 10.0 9.4
37 Suganthi S 22 11803 B G2P1L1 1.53 64 27.34 38.5 YES 260 16 220 LN with Epi 130 NO NO 2.90 9.8 9.5
DURATION OF LABOUR HB % (gms)
IP.No
MASTER CHART
S.No NAME AGE PARITY BMICONTROL /STUDY
38 Devika C 28 11818 B G3P2L2 1.50 56 24.89 38.8 YES 240 18 260 LN with Epi 160 NO NO 2.60 10.8 9.2
39 Kalpana S 35 11787 UB G3P2L2 1.56 67 27.53 38.3 NO 340 20 360 LN with Epi 220 NO NO 3.10 10.2 9.8
40 Revathi C 22 11781 B G2P1L1 1.57 65 26.37 39.0 YES 325 22 280 LN with Epi 265 NO NO 2.70 9.8 9.2
41 Saroja devi S 27 11726 B G2P1L1 1.47 59 27.30 37.4 YES 360 30 300 LN with Epi 140 NO NO 3.30 10.0 9.7
42 Punitha C 24 11415 B G2P1L1 1.61 53 20.45 38.3 YES 340 24 340 LN with Epi 275 NO NO 2.90 9.6 9.0
43 Saranya S 25 11664 B Primi 1.54 64 26.99 38.4 YES 650 43 220 LN with Epi 215 NO NO 3.30 10.2 10.0
44 Pravena C 20 11659 B Primi 1.50 53 23.56 39.1 YES 660 34 320 LN with Epi 280 NO NO 2.90 10.1 9.4
45 Kalpana S 25 11700 B G2P1L1 1.55 60 24.97 38.4 YES 340 15 260 LN with Epi 150 NO NO 2.90 9.8 9.6
46 Sakila C 29 11628 B G2P1L1 1.56 67 27.53 38.2 YES 325 16 240 LN with LP 290 NO NO 2.50 10.2 9.8
47 Merlin S 25 11645 B G2P1L1 1.58 58 23.23 38.4 YES 310 12 120 LN with Epi 65 NO NO 3.10 10.4 10.2
48 Danadhi C 21 12031 B G2P1L1 1.60 82 32.03 37.6 YES 360 25 320 LN with Epi 280 NO NO 2.90 9.8 9.2
49 Amaravathi S 24 11468 B Primi 1.56 57 23.42 38.6 YES 620 32 160 LN with Epi 170 NO NO 3.10 10.2 10.0
50 Meena C 20 11650 B Primi 1.46 60 28.15 38.4 YES 670 52 310 LN with Epi 380 NO NO 3.10 9.8 9.2
51 Sumathi S 24 11654 B G2P1L1 1.52 52 22.51 38.1 YES 350 20 130 LN with Epi 160 NO NO 2.50 10.4 10.0
52 Dhanalakshmi C 20 11854 B G2P1L1 1.54 54 22.77 37.6 YES 320 15 170 LN with Epi 170 NO NO 3.10 10.6 10.0
53 Padmini S 21 11528 B Primi 1.55 60 24.97 38.0 YES 645 25 280 LN with Epi 150 NO NO 2.90 11.0 10.8
54 Kavitha C 21 11491 UB Primi 1.53 53 22.64 38.0 YES 640 20 340 LN with Epi 60 NO NO 3.10 12.0 11.6
55 Rani S 25 11860 B G2P1L1 1.48 52 23.74 38.2 YES 345 22 240 LN with Epi 210 NO NO 2.30 10.4 10.2
56 Narmadha C 21 11922 B G2P1L1 1.47 58 26.84 37.6 NO 350 18 180 LN with Epi 275 NO NO 2.60 10.2 9.8
57 Sivanthika S 24 11488 B Primi 1.52 62 26.84 37.4 YES 620 30 240 LN with Epi 220 NO NO 3.10 9.8 9.5
58 Shakira C 18 10884 B Primi 1.51 60 26.31 37.6 YES 630 28 170 LN with Epi 280 NO NO 3.70 10.2 9.4
59 Eswari S 23 11600 B G2P1L1 1.53 52 22.21 38.4 YES 345 15 120 LN with Epi 140 NO NO 3.30 10.4 10.0
60 Rahima C 35 13269 B G2P1L1 1.58 60 24.03 38.2 YES 360 28 320 LN with Epi 275 NO NO 2.20 10.2 9.6
61 Premila S 24 13646 B Primi 1.60 58 22.66 37.4 YES 580 30 220 LN with Epi 120 NO NO 3.20 9.8 9.5
62 Minalgodi C 26 11640 B Primi 1.52 48 20.78 38.4 YES 590 35 340 LN with Epi 170 NO NO 2.80 9.6 9.0
63 Maheswari S 24 11604 B G2P1L1 1.51 50 21.93 39.4 YES 280 12 120 LN with Epi 85 NO NO 3.30 10.2 10.0
64 Mary C 31 13580 B G3P2L2 1.52 55 23.81 39.1 YES 355 24 360 LN with Epi 290 NO NO 2.70 10.4 9.4
65 Venilla S 24 13756 B G2P1L1 1.53 53 22.64 38.1 NO 325 17 210 LN with Epi 110 NO NO 2.60 9.8 9.5
66 Poongodi C 23 11578 B Primi 1.53 63 26.91 39.1 YES 560 25 140 LN with Epi 110 NO NO 2.80 10.2 9.8
67 ManoRanjini C 21 14634 B Primi 1.54 63 26.56 38.2 YES 640 45 420 LN with Epi 400 NO NO 3.60 9.8 9.1
68 Nathiya S 26 11580 B Primi 1.52 50 21.64 38.4 YES 540 20 120 LN with Epi 80 NO NO 3.30 9.8 9.5
69 Gayathri C 22 14652 B Primi 1.48 61 27.85 38.5 NO 560 25 280 LN with Epi 180 NO NO 2.90 10.2 9.8
70 Meena S 24 11650 B Primi 1.52 60 25.97 38.6 YES 610 15 350 LN with Epi 120 NO NO 3.00 10.4 10.1
71 Malliga C 23 14773 B G2P1L1 1.59 51 20.17 37.4 YES 360 24 300 LN with Epi 320 NO NO 3.10 10.2 9.4
72 Shakila S 21 11628 B Primi 1.60 65 25.39 38.5 YES 580 25 240 LN with Epi 250 NO NO 3.30 10.2 9.8
73 Nagavalli C 26 14651 B G2P1L1 1.48 49 22.37 37.3 YES 340 30 320 LN with Epi 340 NO NO 3.30 10.6 9.8
74 Devi S 19 14662 B Primi 1.54 57 24.03 37.4 YES 610 15 180 LN with Epi 180 NO NO 2.90 10.4 10.0
75 Ilakia C 21 14776 B Primi 1.56 60 24.65 38.6 YES 620 20 280 LN 190 NO NO 2.10 10.2 9.2
76 Shamshath S 28 14065 B Primi 1.53 66 28.19 38.4 YES 680 25 160 LN with Epi 210 NO NO 2.30 10.2 9.8
77 Jansi Rani C 21 14804 B G2P1L1 1.59 66 26.11 38.5 YES 345 28 300 LN with Epi 360 NO NO 2.10 9.8 9.1
78 Chandra Kala S 25 14120 B G2P1L1 1.53 51 21.79 38.5 YES 350 24 260 LN 140 NO NO 2.50 10.4 10.1
79 Usha Mary C 22 14901 B Primi 1.46 51 23.93 37.4 YES 670 35 360 LN with Epi 380 NO NO 3.30 10.6 9.4
80 Mekala S 23 14128 B Primi 1.49 56 25.22 37.4 YES 625 32 250 LN with Epi 210 NO NO 3.20 9.8 9.5
81 Supriya C 26 14910 B G2P1L1 1.56 43 17.67 38.4 NO 360 35 440 LN with Epi 390 NO NO 2.60 10.4 9.5
82 KalaiSelvi S 26 14023 B Primi 1.53 69 29.48 38.4 YES 695 18 280 LN with Epi 120 NO NO 2.80 10.2 9.8
83 Menaga C 24 14917 B Primi 1.54 58 24.46 38.5 YES 650 24 400 LN with Epi 380 NO NO 2.60 10.4 9.5
84 Jamini S 22 14129 B G2P1L1 1.59 61 24.13 38.6 YES 320 12 150 LN 85 NO NO 3.40 10.4 10.2
85 Shobana C 27 15243 B G2P1L1 1.71 65 22.23 38.4 YES 345 35 520 LN with Epi 850 YES YES 2.50 10.6 9.0
86 Hemalatha S 25 14252 B Primi 1.56 55 22.60 38.1 YES 580 20 220 LN with Epi 215 NO NO 2.50 10.2 10.1
87 Vidhya C 32 14387 B G2P1L1 1.53 65 27.77 39.1 YES 320 15 220 LN with Epi 180 NO NO 2.80 10.4 9.4
88 Nagalakshmi S 21 14252 B Primi 1.54 51 21.50 38.4 YES 620 18 120 LN with Epi 130 NO NO 2.80 9.8 9.6
89 Jeyanthi C 24 14434 B Primi 1.54 63 26.56 38.8 NO 650 30 300 LN with Epi 360 NO NO 2.80 10.2 9.4
90 DesaRani S 22 14414 B Primi 1.66 64 23.23 37.4 NO 640 35 260 LN with Epi 210 NO NO 2.60 11.0 10.8
91 Nathiya C 23 14439 B G2P1L1 1.61 61 23.53 38.4 YES 345 20 240 LN with Epi 190 NO NO 2.60 10.5 10.2
92 Devi S 20 14062 B Primi 1.55 61 25.39 38.4 YES 580 18 280 LN with Epi 140 NO NO 3.20 10.4 10.2
93 Lalitha C 21 14167 B Primi 1.55 60 24.97 38.6 YES 620 24 200 LN with Epi 280 NO NO 3.10 9.8 9.4
94 Thulasi S 23 14561 B Primi 1.61 66 25.46 38.1 YES 545 10 80 LN with Epi 75 NO NO 2.80 10.3 10.2
95 Janagi C 25 14423 B G2P1L1 1.56 60 24.65 38.8 NO 355 20 320 LN with LP 285 NO NO 3.80 10.1 9.4
96 Aanadhi S 26 14574 B Primi 1.57 49 19.88 38.2 YES 645 18 120 LN with Epi 150 NO NO 3.90 10.2 9.8
97 Nagalakshmi C 21 14252 B G2P1L1 1.51 71 31.14 37.6 YES 355 14 280 LN with Epi 275 NO NO 2.70 9.8 9.1
98 Indhira S 23 14623 B Primi 1.65 63 23.14 38.3 YES 620 25 360 LN with Epi 220 NO NO 2.70 10.0 9.8
99 Thameema C 23 14184 UB G2P1L1 1.56 64 26.30 37.2 YES 345 15 120 LN with Epi 80 NO NO 3.20 10.2 9.4
100 UmaRani S 24 14286 B Primi 1.61 67 25.85 37.4 YES 680 20 220 LN with Epi 120 NO NO 3.10 9.8 9.6
101 Jalaja C 25 14269 B G2P1L1 1.61 66 25.46 37.4 YES 320 17 280 LN with Epi 170 NO NO 2.60 10.2 9.4
102 Shanthakumari S 27 14229 B Primi 1.51 57 25.00 38.2 YES 680 35 110 LN with Epi 360 NO NO 2.70 9.8 9.6
103 Rajeswari C 21 14326 B Primi 1.54 65 27.41 38.1 YES 645 26 240 LN with Epi 180 NO NO 3.00 10.2 9.2
104 Vasanthi S 19 14337 B Primi 1.58 66 26.44 37.4 YES 625 22 280 LN 140 NO NO 2.80 10.4 10.1
105 Rukmani C 23 14380 B G2P1L1 1.57 68 27.59 38.5 YES 345 24 240 LN with Epi 180 NO NO 3.20 10.0 9.2
106 Priyanka S 26 14367 B G3P2L2 1.62 54 20.58 38.6 NO 350 13 240 LN with Epi 130 NO NO 3.00 9.8 9.6
107 Vidya C 24 14387 B G2P1L1 1.48 60 27.39 38.4 YES 345 27 340 LN with Epi 360 NO NO 3.40 10.2 10.0
108 Kavitha S 23 14382 UB Primi 1.51 54 23.68 39.2 YES 655 36 280 LN with Epi 320 NO NO 3.00 10.2 9.8
109 Nathiya C 23 14439 B Primi 1.55 65 27.06 39.0 YES 680 34 320 LN with Epi 380 NO NO 3.40 9.8 9.6
110 Shanthi S 24 14410 B Primi 1.57 68 27.59 38.4 YES 645 20 120 LN with Epi 85 NO NO 2.60 10.2 10.0
111 Abirami C 26 14443 B G2P1L1 1.56 61 25.07 38.1 YES 340 15 200 LN with Epi 120 NO NO 3.00 10.4 10.2
112 Lokeswari S 25 14389 B G2P1L1 1.61 83 32.02 37.4 YES 320 12 160 LN 180 NO NO 3.00 9.8 9.4
113 Manjula C 23 14356 B Primi 1.59 59 23.34 38.2 YES 670 43 300 LN with Epi 950 YES YES 3.20 10.2 9.0
114 Tamilarasi S 23 14388 B Primi 1.47 61 28.23 38.1 YES 640 22 140 LN with Epi 210 NO NO 3.20 10.6 10.0
115 Banu C 21 14392 B Primi 1.57 58 23.53 38.4 YES 650 24 280 LN with Epi 175 NO NO 3.20 10.0 9.8
116 Jeyanthi S 24 14392 B Primi 1.53 62 26.49 37.6 YES 550 18 120 LN with Epi 110 NO NO 3.50 10.4 10.0
117 Chellakili C 27 14410 B G2P1L1 1.52 60 25.97 38.1 YES 340 24 400 LN with Epi 450 NO NO 2.70 10.2 9.8
118 Nirosha S 23 14469 B Primi 1.47 60 27.77 37.4 YES 640 32 260 LN with Epi 310 NO NO 2.80 9.8 9.6
119 Eswari C 31 14320 B G2P1L1 1.51 50 21.93 39.1 NO 280 24 260 LN with Epi 280 NO NO 3.20 10.4 10.0
120 Meenachi S 26 14344 B G2P1L1 1.58 50 20.03 38.4 YES 265 18 240 LN with Epi 160 NO NO 3.00 10.2 9.8
121 Vanitha C 21 14493 B Primi 1.51 59 25.88 39.2 YES 620 35 340 LN with Epi 150 NO NO 2.90 10.4 10.2
122 Suganya S 22 14504 B Primi 1.47 48 22.21 38.5 YES 580 28 280 LN with Epi 150 NO NO 3.20 10.6 10.0
123 Priya C 21 14325 B Primi 1.59 64 25.32 39.1 YES 670 36 360 LN with Epi 380 NO NO 3.20 9.8 9.4
124 Jothy S 27 14472 B Primi 1.55 59 24.56 38.4 YES 620 44 360 LN with Epi 440 NO NO 2.10 9.8 9.2
125 Gayathri C 26 14412 B G2P1L1 1.53 56 23.92 37.6 YES 300 15 280 LN with Epi 180 NO NO 2.80 10.4 10.3
126 Premalatha S 21 14373 B Primi 1.58 65 26.04 38.3 YES 590 18 240 LN with Epi 140 NO NO 2.10 10.2 9.8
127 Revathy C 24 14531 B G2P1L1 1.52 65 28.13 38.1 YES 285 20 260 LN with Epi 290 NO NO 2.20 10.0 9.6
128 Rajeswari S 20 14515 B Primi 1.45 50 23.78 39.2 YES 620 18 380 LN with Epi 145 NO NO 3.20 10.2 10.0
129 Aasha C 23 14454 B Primi 1.52 50 21.64 38.6 YES 680 26 360 LN with Epi 440 NO NO 2.40 10.4 9.6
130 Samantha S 23 14524 B Primi 1.55 42 17.48 39.4 YES 640 18 120 LN with Epi 210 NO NO 2.50 9.8 9.6
131 Supriya C 22 14910 B Primi 1.48 55 25.11 39.1 YES 680 35 460 LN with Epi 400 NO NO 3.10 10.2 9.8
132 Nathiya S 26 14528 B G2P1L1 1.53 57 24.35 37.5 YES 320 12 110 LN with LP 120 NO NO 2.50 10.0 9.8
133 Meenachi C 21 14708 B Primi 1.52 68 29.43 38.4 YES 585 32 440 LN with Epi 380 NO NO 2.70 9.8 9.2
134 Aathi S 24 12234 B Primi 1.70 64 22.15 37.1 YES 620 14 220 LN with Epi 160 NO NO 2.40 10.4 10.2
135 Saroja devi C 22 14570 B G2P1L1 1.58 60 24.03 37.4 YES 320 35 440 LN with Epi 800 YES YES 3.30 10.2 9.0
136 Bavani S 25 14656 B Primi 1.52 64 27.70 37.4 YES 540 20 260 LN with Epi 180 NO NO 2.70 10.2 10.0
137 Poongodi C 28 14665 B G2P1L1 1.55 54 22.48 38.2 YES 280 14 220 LN with Epi 90 NO NO 2.40 10.4 9.8
138 Meena S 22 14708 B Primi 1.53 62 26.49 38.4 YES 545 10 120 LN with Epi 75 NO NO 2.70 10.2 10.0
139 Rajeswari C 21 14855 B Primi 1.53 50 21.36 38.5 YES 580 28 320 LN with Epi 400 NO NO 2.70 9.8 9.2
140 Gunasundari S 21 14729 B Primi 1.60 60 23.44 37.5 NO 590 24 220 LN with Epi 210 NO NO 2.50 10.2 10.0
141 Devika C 24 14882 B G2P1L1 1.65 63 23.14 38.2 YES 350 18 260 LN with LP 285 NO NO 2.50 10.4 9.6
142 Abirami S 25 14831 B G2P1L1 1.54 59 24.88 38.5 NO 310 15 120 LN with Epi 130 NO NO 3.00 9.8 9.6
143 UshaMary C 23 14901 B Primi 1.54 60 25.30 37.4 YES 620 40 300 LN with Epi 290 NO NO 3.10 9.8 9.4
144 Aanadhi S 26 14896 B Primi 1.55 59 24.56 38.3 YES 640 45 300 LN with Epi 320 NO NO 3.70 10.0 9.8
145 Latha C 22 15514 B Primi 1.60 65 25.39 38.1 YES 680 55 340 LN with Epi 750 YES YES 2.70 10.2 9.0
146 Kalaivani S 21 15480 B Primi 1.50 70 31.11 39.2 YES 560 25 140 LN 60 NO NO 2.60 9.8 9.6
147 Tamilselvi C 25 15461 B G2P1L1 1.45 48 22.83 37.4 YES 320 24 280 LN with Epi 360 NO NO 3.80 10.0 9.2
148 Pusphalatha S 20 15453 B Primi 1.55 63 26.22 38.2 YES 620 20 180 LN with Epi 140 NO NO 3.10 10.2 10.0
149 Sumathy C 22 15466 B G2P1L1 1.64 62 23.05 38.1 NO 280 25 160 LN with Epi 290 NO NO 2.60 10.4 9.8
150 Prema S 27 15473 B Primi 1.60 65 25.39 39.2 YES 680 48 330 LN with Epi 700 YES YES 2.50 9.8 9.6
151 Flora C 23 15444 B Primi 1.60 66 25.78 37.5 YES 645 32 280 LN with Epi 350 NO NO 3.00 10.2 9.4
152 Yuvarani S 28 15361 B Primi 1.53 64 27.34 39.4 YES 560 25 220 LN with Epi 100 NO NO 2.90 10.6 10.2
153 Asta Lakshmi C 21 15392 B Primi 1.50 56 24.89 37.4 YES 640 22 260 LN with Epi 260 NO NO 2.60 11.0 10.2
154 Vishalakshi S 32 15395 B G2P1L1 1.56 67 27.53 37.6 YES 320 14 220 LN with Epi 120 NO NO 3.10 10.2 10.0
155 Gokila C 28 15387 UB G2P1L1 1.57 65 26.37 39.2 YES 280 16 260 LN with Epi 150 NO NO 2.70 10.4 10.2
156 Sumathy S 24 15384 B Primi 1.47 59 27.30 38.3 YES 625 22 200 LN with Epi 140 NO NO 3.30 10.2 9.8
157 Jannath C 24 15530 B Primi 1.61 53 20.45 37.4 YES 645 40 340 LN with Epi 650 YES YES 2.90 10.4 9.6
158 NaseemaBanu S 21 15362 B Primi 1.54 64 26.99 38.5 YES 585 23 180 LN with Epi 160 NO NO 3.30 10.8 10.6
159 Mahalakshmi C 23 15338 B Primi 1.50 53 23.56 39.1 YES 640 25 320 LN with Epi 240 NO NO 2.90 10.6 10.0
160 Padmavathy S 26 15327 B G2P1L1 1.55 60 24.97 38.5 YES 340 18 240 LN with Epi 320 NO NO 2.90 9.8 9.4
161 Mahalakshmi C 21 15357 B Primi 1.56 67 27.53 37.6 YES 580 17 200 LN with Epi 230 NO NO 2.50 10.4 9.8
162 Malar S 23 15332 UB Primi 1.58 58 23.23 39.2 YES 620 35 260 LN with Epi 450 NO NO 3.10 10.6 10.2
163 Malathy C 22 15313 B Primi 1.60 82 32.03 38.6 YES 580 32 300 LN with Epi 275 NO NO 2.90 10.2 9.2
164 Poornima S 26 15351 B Primi 1.56 57 23.42 39.3 YES 620 45 320 LN with Epi 360 NO NO 3.10 9.8 9.6
165 Sangeetha C 24 15328 B G2P1L1 1.46 60 28.15 38.6 YES 320 28 320 LN with Epi 280 NO NO 3.10 10.4 9.6
166 Banupriya S 22 15308 B G2P1L1 1.51 59 25.88 39.4 YES 240 12 100 LN with Epi 75 NO NO 2.60 10.6 10.4
167 Rohini C 21 15324 B Primi 1.52 61 26.40 38.2 YES 580 45 380 LN with Epi 260 NO NO 3.40 9.8 9.0
168 Vanitha S 27 15339 B G2P1L1 1.50 48 21.33 38.3 YES 280 23 240 LN with Epi 180 NO NO 3.10 10.2 9.8
169 Amitha C 22 14951 B G2P1L1 1.46 59 27.68 38.6 YES 300 18 260 LN with Epi 280 NO NO 2.70 10.4 9.8
170 Benazeer S 28 15296 B G3P2L2 1.50 58 25.78 37.3 YES 280 15 120 LN with Epi 110 NO NO 2.80 10.2 10.0
171 Thenmozhi C 23 15311 B Primi 1.57 49 19.88 37.5 YES 655 52 340 LN with Epi 560 NO YES 2.90 10.6 10.0
172 Lakshmi S 19 15322 B G2P1L1 1.58 63 25.24 37.4 YES 320 18 280 LN with Epi 340 NO NO 3.10 10.4 9.8
173 Deepa C 27 16473 B G2P1L1 1.46 47 22.05 38.2 YES 340 30 360 LN with Epi 740 YES YES 3.10 9.8 8.8
174 Chithra S 22 16468 B G2P1L1 1.52 55 23.81 38.4 YES 285 20 200 LN with Epi 150 NO NO 2.70 10.4 10.2
175 Anitha C 21 16493 B Primi 1.54 58 24.46 38.5 YES 640 18 280 LN with Epi 250 NO NO 2.00 11.0 10.2
176 Kalaivani S 26 16478 B G2P1L1 1.51 64 28.07 37.5 YES 220 10 80 LN with Epi 80 NO NO 2.10 10.2 10.0
177 Selvi C 21 16475 B Primi 1.57 64 25.96 39.2 YES 585 17 300 LN with Epi 140 NO NO 2.20 10.8 10.2
178 Kumudha S 23 22 B G2P1L1 1.51 49 21.49 37.4 YES 320 18 120 LN with LP 110 NO NO 2.30 10.2 10.0
179 Muniammal C 27 20 B G2P1L1 1.45 49 23.31 39.1 YES 360 25 480 LN with LP 1,000 YES YES 3.10 10.8 9.0
180 Suriya S 21 23 B Primi 1.47 54 24.99 38.2 YES 620 35 380 LN with Epi 340 NO NO 3.00 10.4 10.2
181 Desam C 22 37 B Primi 1.54 41 17.29 39.3 YES 680 32 320 LN with Epi 480 NO NO 2.40 9.8 9.2
182 Saranya S 26 36 B Primi 1.51 67 29.38 37.5 YES 580 24 220 LN with Epi 210 NO NO 2.60 10.2 10.0
183 Drish C 25 34 B G2P1L1 1.52 56 24.24 38.4 YES 280 18 280 LN with Epi 340 NO NO 2.40 10.4 10.0
184 Rubavathy S 23 27 B G2P1L1 1.57 59 23.94 37.4 YES 320 22 340 LN with LP 220 NO NO 3.20 10.0 9.6
185 Kumari C 23 55 B Primi 1.69 63 22.06 37.5 NO 655 26 310 LN with Epi 265 NO NO 2.30 10.2 9.2
186 Kasthuri S 26 50 B Primi 1.54 55 23.19 38.4 YES 675 17 280 LN with Epi 225 NO NO 2.30 10.6 10.4
187 Dhanapriya C 26 12 B G2P1L1 1.51 63 27.63 38.1 YES 320 16 240 LN with Epi 245 NO NO 2.60 10.8 10.2
188 Shabeena S 24 61 B G2P1L1 1.52 59 25.54 37.4 NO 310 20 260 LN 205 NO NO 2.60 10.2 10.0
189 Murugeshwari C 21 70 B Primi 1.52 61 26.40 38.2 NO 640 32 280 LN with Epi 255 NO NO 2.60 9.8 9.0
190 Murugavalli S 27 62 B Primi 1.64 62 23.05 38.1 YES 580 23 120 LN with Epi 240 NO NO 2.40 10.2 10.0
191 Hemaltha C 22 71 B G2P1L1 1.59 59 23.34 38.6 YES 240 13 140 LN 90 NO NO 2.40 10.4 9.8
192 Kanmani S 33 16424 B G2P1L1 1.53 59 25.20 38.3 YES 320 17 160 LN with Epi 240 NO NO 3.00 10.0 9.8
193 Udaya C 21 57 B Primi 1.53 58 24.78 38.2 YES 675 24 300 LN with Epi 330 NO NO 2.90 9.8 9.2
194 Parvathy S 22 96 B Primi 1.59 64 25.32 38.4 YES 585 15 140 LN with Epi 75 NO NO 2.60 10.2 9.8
195 Vaanmathy C 24 103 UB Primi 1.54 58 24.46 38.6 YES 600 35 320 LN with Epi 320 NO NO 3.60 11.0 10.4
196 Eshwari S 28 16495 B G2P1L1 1.45 47 22.35 38.4 YES 260 17 130 LN with Epi 210 NO NO 3.70 10.5 10.2
197 Gayathri C 21 123 B Primi 1.49 69 31.08 38.6 YES 655 40 380 LN with Epi 800 YES YES 2.50 10.2 9.0
198 Indrani S 23 108 B Primi 1.63 61 22.96 37.3 YES 700 45 340 LN with Epi 750 YES YES 2.50 10.4 9.0
199 Indumathy C 22 125 B Primi 1.54 62 26.14 39.1 YES 710 35 420 LN with Epi 310 NO NO 3.00 10.8 10.0
200 Marykrishna S 28 76 B Primi 1.59 65 25.71 37.4 YES 685 23 240 LN with Epi 110 NO NO 2.90 10.0 9.8
201 Arshalatchmi S 22 149 B G2P1L1 1.54 61 25.72 38.2 YES 265 12 150 LN with Epi 130 NO NO 3.50 11.0 10.8
202 Karpagam C 26 187 B Primi 1.52 60 25.97 38.1 YES 655 17 420 LN with Epi 120 NO NO 2.80 10.2 9.4
203 Shanthini S 25 155 B G2P1L1 1.48 60 27.39 38.4 YES 285 14 120 LN with Epi 220 NO NO 2.70 10.6 10.4
204 Jayalakshmi C 27 144 B G2P1L1 1.51 49 21.49 38.2 YES 320 18 260 LN with Epi 250 NO NO 2.30 9.6 9.0
205 Meena S 20 156 B Primi 1.58 51 20.43 39.1 YES 665 22 360 LN with Epi 150 NO NO 3.00 9.8 9.6
206 Sridevi C 20 133 B Primi 1.51 59 25.88 38.8 YES 675 36 340 LN with Epi 280 NO NO 2.90 9.8 9.0
207 Mahalakshmi S 23 158 B Primi 1.48 48 21.91 39.6 YES 650 24 220 LN with Epi 220 NO NO 3.20 9.8 9.6
208 Latha C 22 171 B Primi 1.59 63 24.92 37.5 YES 685 24 340 LN 270 NO NO 3.10 10.9 10.2
209 Rajalakshmi S 23 172 B Primi 1.55 59 24.56 38.1 YES 645 32 240 LN with Epi 150 NO NO 2.10 9.8 9.6
210 Lakshmi C 21 175 B G2P1L1 1.53 56 23.92 37.6 YES 255 17 280 LN with Epi 130 NO NO 2.80 9.8 9.2
211 Tamil mani S 26 169 B Primi 1.59 65 25.71 38.5 YES 545 20 175 LN with Epi 80 NO NO 2.10 10.8 10.6
212 Gomathy C 22 16492 B G2P1L1 1.52 66 28.57 38.5 YES 320 18 260 LN with Epi 290 NO NO 2.20 10.2 9.4
213 Deepa S 24 179 B G2P1L1 1.45 50 23.78 38.2 NO 265 15 180 LN with Epi 75 NO NO 3.30 9.8 9.4
214 Anitha C 22 186 B G2P1L1 1.52 50 21.64 38.3 YES 340 28 360 LN with Epi 240 NO NO 2.50 9.8 9.0
215 Jagadeeshwari S 21 185 B G2P1L1 1.56 45 18.49 38.2 YES 300 22 245 LN with Epi 230 NO NO 2.50 9.6 9.4
216 Bhavani C 24 59 B Primi 1.48 55 25.11 37.5 YES 700 35 480 LN with Epi 270 NO NO 3.10 10.4 9.8
217 Suganya S 28 190 B G2P1L1 1.53 57 24.35 38.1 YES 320 22 260 LN 150 NO NO 2.50 10.2 10.0
218 Shobhana C 22 196 B G2P1L1 1.52 68 29.43 37.6 YES 345 26 410 LN with Epi 270 NO NO 2.70 10.0 9.2
219 Eshwari S 20 201 B G2P1L1 1.70 62 21.45 38.4 YES 320 28 300 LN with Epi 205 NO NO 2.40 9.8 9.4
220 Bharathy C 22 194 B Primi 1.58 60 24.03 37.2 YES 695 24 460 LN with Epi 220 NO NO 3.30 10.1 9.2
221 Deivanai S 21 197 B Primi 1.53 64 27.34 39.1 YES 565 15 120 LN with Epi 155 NO NO 2.80 9.5 9.3
222 Vaideeshwari C 23 211 B G2P1L1 1.55 56 23.31 38.2 YES 280 12 210 LN with Epi 100 NO NO 2.40 10.3 9.4
223 Rajathi S 24 205 B G2P1L1 1.53 62 26.49 39.2 YES 285 18 240 LN with Epi 210 NO NO 2.70 9.8 9.6
224 Hemalatha C 24 207 B G2P1L1 1.53 50 21.36 37.6 YES 360 22 320 LN with Epi 290 NO NO 2.60 10.2 9.6
225 Megala S 22 209 B G2P1L1 1.60 60 23.44 38.3 YES 285 13 130 LN with Epi 140 NO NO 2.50 10.6 10.4
226 Narmalatha C 21 212 B Primi 1.65 62 22.77 37.5 YES 655 23 240 LN with Epi 280 NO NO 2.50 10.4 9.8
227 Vijaya S 28 202 B G2P1L1 1.55 59 24.56 37.2 YES 285 24 270 LN with Epi 220 NO NO 3.00 10.0 9.8
228 Devi C 23 210 B G2P1L1 1.54 60 25.30 37.2 YES 325 14 200 LN with Epi 140 NO NO 3.10 9.8 9.6
229 Venilla S 22 237 B Primi 1.56 59 24.24 38.5 YES 645 28 240 LN with Epi 170 NO NO 3.70 9.8 9.2
230 Desam C 32 246 B G2P1L1 1.60 63 24.61 38.1 YES 360 22 310 LN with Epi 260 NO NO 2.70 9.8 9.2
231 Jayanthi S 26 256 B G2P1L1 1.50 70 31.11 39.2 YES 240 13 80 LN with Epi 120 NO NO 2.60 9.6 9.4
232 Deepa C 21 257 B G2P1L1 1.44 48 23.15 38.1 YES 325 18 280 LN 285 NO NO 2.60 9.8 9.4
233 Gokila S 27 220 B Primi 1.56 64 26.30 39.2 YES 565 20 120 LN with Epi 75 NO NO 3.10 10.0 9.8
234 Parvin C 24 252 B Primi 1.64 62 23.05 38.6 YES 545 25 130 LN with Epi 300 NO NO 2.60 10.2 9.6
235 Mumtaj Begam S 27 239 B G2P1L1 1.61 65 25.08 39.4 YES 360 24 380 LN with Epi 210 NO NO 2.50 10.4 10.2
236 Puvi Arasi C 27 259 B G2P1L1 1.60 66 25.78 37.5 YES 340 15 280 LN with Epi 270 NO NO 3.10 10.0 9.4
237 Sagaya Mary S 23 67 B Primi 1.54 64 26.99 38.5 YES 660 18 230 LN with Epi 130 NO NO 2.90 9.8 9.5
238 Revathy C 28 277 B G2P1L1 1.50 56 24.89 38.8 YES 295 15 240 LN with Epi 160 NO NO 2.60 10.6 9.2
239 Varalakshmi S 35 283 UB G2P1L1 1.57 68 27.59 38.3 NO 340 30 350 LN with Epi 210 NO NO 3.10 10.2 9.8
240 Devi C 22 236 B G2P1L1 1.57 65 26.37 37.2 YES 300 24 260 LN with Epi 265 NO NO 2.70 10.2 9.2
241 Soniya S 28 291 B G2P1L1 1.48 59 26.94 39.1 YES 340 25 300 LN with Epi 140 NO NO 3.30 9.8 9.7
242 Logesh Wari C 24 293 B G2P1L1 1.61 54 20.83 38.5 YES 360 28 330 LN with Epi 275 NO NO 2.90 9.6 9.0
243 Pavithra S 24 288 B Primi 1.55 64 26.64 39.2 YES 600 18 220 LN with Epi 225 NO NO 3.30 10.2 10.0
244 Anthoniyammal C 20 302 B Primi 1.50 53 23.56 38.8 YES 655 35 310 LN with Epi 280 NO NO 2.80 10.0 9.4
245 Bhavani S 24 99 B G2P1L1 1.56 60 24.65 38.2 YES 265 25 260 LN with Epi 150 NO NO 2.90 9.8 9.6
246 Vasanthi C 29 316 B G2P1L1 1.56 66 27.12 38.2 YES 245 15 180 LN with LP 280 NO NO 2.50 10.4 10.0
247 Asnath S 25 313 B G2P1L1 1.57 58 23.53 38.4 YES 240 12 110 LN with Epi 65 NO NO 3.10 10.4 10.2
248 Rekha C 21 297 B G2P1L1 1.60 82 32.03 37.6 YES 340 35 320 LN with Epi 290 NO NO 2.90 9.8 9.2
249 Meenakshi S 24 304 B Primi 1.56 58 23.83 38.4 YES 585 28 160 LN with Epi 170 NO NO 3.10 10.2 10.0
250 Revathy C 20 326 B Primi 1.46 60 28.15 38.4 YES 700 35 300 LN with Epi 380 NO NO 3.10 10.0 9.4
251 Nathiya S 24 332 B G2P1L1 1.51 52 22.81 38.1 YES 245 16 120 LN with Epi 160 NO NO 2.50 10.4 10.0
252 Malathi C 20 333 B G2P1L1 1.54 54 22.77 39.0 YES 265 12 140 LN with Epi 170 NO NO 3.10 10.1 10.0
253 Nithiya S 21 310 B G2P1L1 1.54 59 24.88 38.0 YES 345 18 280 LN with Epi 150 NO NO 2.90 11.0 10.8
254 Mumtaj C 21 353 UB Primi 1.53 53 22.64 38.0 YES 675 24 340 LN with Epi 90 NO NO 3.10 11.8 11.6
255 Shalini S 25 317 B G2P1L1 1.47 52 24.06 38.2 YES 300 18 250 LN with Epi 220 NO NO 2.40 10.4 10.2
256 Indumathi C 21 359 B G2P1L1 1.47 59 27.30 37.6 NO 285 14 140 LN with Epi 275 NO NO 2.60 10.2 9.8
257 Indumathi S 23 12357 B Primi 1.52 62 26.84 37.4 YES 600 35 240 LN with Epi 220 NO NO 3.10 9.8 9.5
258 Sasikala C 18 357 B Primi 1.51 60 26.31 37.6 YES 565 25 140 LN with Epi 280 NO NO 3.70 10.2 9.6
259 Abirami S 23 353 B G2P1L1 1.52 52 22.51 38.4 YES 265 16 120 LN with Epi 130 NO NO 3.30 10.4 10.0
260 Seetha C 35 351 B G2P1L1 1.58 59 23.63 38.4 YES 300 28 310 LN with Epi 275 NO NO 2.20 10.4 9.8
261 Kowsalya S 23 276 B Primi 1.59 58 22.94 39.1 YES 575 16 220 LN with Epi 120 NO NO 3.20 9.8 9.5
262 Sulochana C 26 305 B Primi 1.52 48 20.78 38.4 YES 685 24 340 LN with Epi 180 NO NO 2.80 9.8 9.2
263 Jeeva S 24 358 B G2P1L1 1.51 50 21.93 39.2 YES 260 15 120 LN with Epi 85 NO NO 3.30 10.2 10.0
264 Jeyalakshmi C 31 389 B G3P2L2 1.52 55 23.81 39.1 YES 340 40 360 LN with Epi 290 NO NO 2.70 10.4 9.4
265 Sharmila S 24 394 B G2P1L1 1.52 54 23.37 38.1 NO 300 14 220 LN with Epi 110 NO NO 2.50 9.6 9.4
266 Kavitha C 23 16122 B Primi 1.53 63 26.91 39.1 YES 545 13 140 LN with Epi 110 NO NO 2.80 10.2 9.8
267 Roja C 21 344 B Primi 1.54 63 26.56 38.2 YES 700 38 420 LN with Epi 390 NO NO 3.60 9.6 9.1
268 Tamilarasi S 26 396 B G2P1L1 1.52 50 21.64 39.4 YES 285 12 120 LN with Epi 80 NO NO 3.30 9.8 9.5
269 Kokila C 22 395 B Primi 1.48 61 27.85 38.5 NO 600 28 280 LN with Epi 180 NO NO 2.90 10.2 9.8
270 Bharathi S 24 406 B G2P1L1 1.50 59 26.22 38.6 YES 360 20 340 LN with Epi 120 NO NO 3.00 10.5 10.1
271 Manjula C 23 416 B G2P1L1 1.59 51 20.17 39.1 YES 320 25 300 LN with Epi 320 NO NO 3.10 10.2 9.4
272 Rejina Begum S 21 994 B Primi 1.58 65 26.04 38.5 YES 645 22 240 LN with Epi 250 NO NO 3.30 10.0 9.8
273 Mageshwari C 26 988 B G2P1L1 1.48 51 23.28 38.6 YES 360 25 320 LN with Epi 340 NO NO 3.30 10.6 9.8
274 Katheeja S 18 997 B Primi 1.54 57 24.03 39.1 YES 565 18 180 LN with Epi 190 NO NO 2.90 10.2 10.0
275 Priya C 21 998 B Primi 1.56 60 24.65 38.6 YES 675 32 280 LN 190 NO NO 2.10 10.0 9.2
276 Sowmiya S 27 935 B Primi 1.52 66 28.57 38.4 YES 600 22 160 LN with Epi 210 NO NO 2.30 10.2 9.8
277 Sudha C 21 993 B G2P1L1 1.59 64 25.32 38.5 YES 320 35 300 LN with Epi 360 NO NO 2.20 9.8 9.1
278 Rebeca S 25 100 B Primi 1.53 51 21.79 38.5 YES 615 22 260 LN 130 NO NO 2.50 10.4 10.1
279 Sangeetha C 22 981 B Primi 1.46 51 23.93 37.2 YES 655 35 360 LN with Epi 380 NO NO 3.30 10.4 9.4
280 Satha Kumari S 23 1034 B Primi 1.48 57 26.02 39.1 YES 670 22 250 LN with Epi 210 NO NO 3.20 9.8 9.5
281 Ammu Lakshmi C 26 4035 B G2P1L1 1.56 43 17.67 38.4 NO 360 35 440 LN with Epi 390 NO NO 2.60 10.4 9.5
282 Magesh Wari S 26 1036 B Primi 1.53 69 29.48 38.4 YES 600 22 280 LN with Epi 120 NO NO 2.80 9.8 9.4
283 Usha C 24 1037 B G2P1L1 1.54 58 24.46 38.5 YES 345 28 400 LN with Epi 380 NO NO 2.60 10.4 9.5
284 Sratha S 21 995 B G2P1L1 1.58 61 24.44 38.2 YES 275 13 150 LN 85 NO NO 3.40 10.2 10.0
285 Saranya C 27 1002 B G2P1L1 1.71 64 21.89 38.6 YES 360 32 510 LN with Epi 850 YES YES 2.80 10.6 9.0
286 Deepa S 25 1044 B Primi 1.55 55 22.89 38.1 YES 600 25 220 LN with Epi 215 NO NO 2.50 10.2 10.1
287 Sudha C 32 1033 B G2P1L1 1.54 65 27.41 39.1 YES 285 20 220 LN with Epi 180 NO NO 2.80 10.4 9.4
288 Kanniga S 21 1045 B Primi 1.54 51 21.50 38.4 YES 595 15 120 LN with Epi 130 NO NO 2.80 9.6 9.2
289 Chellammal C 24 1050 B Primi 1.54 64 26.99 37.5 NO 700 28 300 LN with Epi 360 NO NO 2.80 10.2 9.4
290 Bhuvaneshwari S 21 1069 B Primi 1.66 64 23.23 39.5 NO 675 25 260 LN with Epi 210 NO NO 2.60 11.0 10.8
291 Jayamala C 23 1067 B Primi 1.62 61 23.24 38.4 YES 655 22 240 LN with Epi 190 NO NO 2.60 10.5 10.2
292 Kalpana S 20 1056 B Primi 1.55 61 25.39 39.2 YES 665 20 280 LN with Epi 140 NO NO 3.20 10.4 10.2
293 Munira C 21 1031 B G2P1L1 1.56 59 24.24 38.6 YES 300 17 210 LN with Epi 280 NO NO 3.10 9.6 9.2
294 Radhika S 22 1058 B Primi 1.61 66 25.46 38.1 YES 540 15 80 LN with Epi 75 NO NO 2.80 10.3 10.2
295 Nandhini C 25 961 B Primi 1.57 60 24.34 37.5 NO 700 18 320 LN with LP 285 NO NO 3.80 10.1 9.4
296 Sudha S 26 10687 B Primi 1.57 50 20.28 38.2 YES 575 17 140 LN with Epi 150 NO NO 3.80 10.2 9.8
297 Kalaiarasi C 21 1049 B G2P1L1 1.52 71 30.73 37.6 YES 320 22 280 LN with Epi 275 NO NO 2.70 9.8 9.1
298 Kavitha S 22 1077 B Primi 1.65 63 23.14 38.3 YES 700 25 360 LN with Epi 220 NO NO 2.70 10.0 9.8
299 Jeevitha C 23 1079 UB Primi 1.57 64 25.96 37.2 YES 560 16 120 LN with Epi 80 NO NO 3.20 10.2 9.4
300 Devika S 24 1082 B Primi 1.61 66 25.46 39.1 YES 655 28 200 LN with Epi 130 NO NO 3.10 9.8 9.6
301 Pushpalatha C 25 1085 B G2P1L1 1.62 66 25.15 37.4 YES 320 18 280 LN with Epi 170 NO NO 2.60 10.2 9.4
302 Alamelu S 27 1114 B Primi 1.51 57 25.00 38.2 YES 565 24 110 LN with Epi 360 NO NO 2.70 9.8 9.6
303 Usha C 22 1115 B G2P1L1 1.55 66 27.47 38.1 YES 320 22 240 LN with Epi 180 NO NO 3.00 10.2 9.2
304 Sarnya S 19 1133 B Primi 1.58 66 26.44 39.1 YES 655 18 280 LN 130 NO NO 2.80 10.4 10.1
305 Saranya C 23 1150 B Primi 1.57 68 27.59 38.5 YES 645 23 240 LN with Epi 180 NO NO 3.20 10.0 9.2
306 Mobin S 26 1149 B G3P2L2 1.62 54 20.58 38.6 NO 320 18 240 LN with Epi 130 NO NO 3.00 9.8 9.6
307 Kalaiselvi C 25 1157 B G2P1L1 1.49 59 26.58 38.4 YES 340 32 340 LN with Epi 360 NO NO 3.40 10.2 10.0
308 Merru nisha S 23 1161 UB Primi 1.51 54 23.68 39.0 YES 675 35 280 LN with Epi 320 NO NO 3.00 10.2 9.8
309 Benitha C 24 1163 B G2P1L1 1.56 65 26.71 37.5 YES 340 28 310 LN with Epi 370 NO NO 3.40 9.8 9.6
310 Selvi S 24 962 B Primi 1.57 68 27.59 38.4 YES 600 22 120 LN with Epi 85 NO NO 2.50 10.0 9.8
311 Vasanthi C 27 1166 B G2P1L1 1.58 61 24.44 38.1 YES 300 19 210 LN with Epi 120 NO NO 3.00 10.4 10.2
312 Saranya S 25 1185 B G2P1L1 1.61 82 31.63 37.6 YES 265 14 160 LN 180 NO NO 3.00 9.8 9.4
313 Tamilarasi C 23 1171 B Primi 1.59 59 23.34 38.2 YES 700 45 480 LN with Epi 960 YES YES 3.20 10.2 9.0
314 Vijayalakshmi S 23 1186 B Primi 1.47 61 28.23 38.1 YES 575 32 140 LN with Epi 210 NO NO 3.20 10.6 10.0
315 Vanitha C 22 1154 B G2P1L1 1.57 58 23.53 38.4 YES 320 17 280 LN with Epi 175 NO NO 3.20 10.0 9.8
316 Logesh Wari S 24 1197 B Primi 1.53 63 26.91 37.6 YES 565 25 120 LN with Epi 110 NO NO 3.50 10.4 10.0
317 Hari priya C 27 1194 B G2P1L1 1.55 60 24.97 38.3 YES 360 24 400 LN with Epi 450 NO NO 2.70 10.2 9.8
318 Shobhana S 23 1133 B Primi 1.47 60 27.77 37.4 YES 575 35 260 LN with Epi 310 NO NO 2.80 9.8 9.6
319 Suganya C 31 1202 B G2P1L1 1.51 52 22.81 39.1 NO 300 21 280 LN with Epi 280 NO NO 3.20 10.4 10.0
320 Nadhiya devi S 26 1189 B G2P1L1 1.58 50 20.03 38.4 YES 340 15 240 LN with Epi 160 NO NO 3.00 10.2 9.8
321 Sri vijaya C 22 1205 B Primi 1.52 59 25.54 39.0 YES 700 35 340 LN with Epi 150 NO NO 2.90 10.4 10.2
322 Priyanka S 22 1240 B Primi 1.47 48 22.21 38.5 YES 655 25 280 LN with Epi 150 NO NO 3.20 10.6 10.0
323 Sangeetha C 27 1260 B Primi 1.59 62 24.52 39.1 YES 715 32 360 LN with Epi 380 NO NO 3.20 9.6 9.5
324 Rani S 27 1271 B Primi 1.55 59 24.56 38.4 YES 675 45 360 LN with Epi 440 NO NO 2.20 9.8 9.2
325 Dhanalakshmi C 27 1253 B Primi 1.52 56 24.24 37.6 YES 655 18 280 LN with Epi 180 NO NO 2.80 10.4 10.3
326 Bhavani S 21 1278 B Primi 1.58 66 26.44 38.1 YES 645 20 240 LN with Epi 150 NO NO 2.10 10.2 9.8
327 Bhathar nisha C 24 1274 B G2P1L1 1.50 65 28.89 38.1 YES 340 15 260 LN with Epi 290 NO NO 2.20 10.0 9.6
328 Logamma S 20 1317 B Primi 1.45 50 23.78 39.4 YES 685 26 380 LN with Epi 135 NO NO 3.20 10.0 9.8
329 Bharathi C 24 1315 B Primi 1.51 50 21.93 38.6 YES 690 35 360 LN with Epi 440 NO NO 2.40 10.4 9.6
330 Vijayalakshmi S 23 1320 B G2P1L1 1.55 42 17.48 39.4 YES 255 15 120 LN with Epi 210 NO NO 2.50 9.8 9.6
331 Shakeela C 22 1321 B Primi 1.48 55 25.11 39.3 YES 710 35 460 LN with Epi 400 NO NO 3.10 10.2 9.8
332 Janaki S 26 1324 B Primi 1.53 56 23.92 39.1 YES 540 18 110 LN with LP 120 NO NO 2.50 10.0 9.8
333 Swathi C 22 1306 B G2P1L1 1.51 68 29.82 38.2 YES 360 40 440 LN with Epi 370 NO NO 2.70 9.6 9.0
334 Reena S 24 1357 B Primi 1.70 64 22.15 37.1 YES 595 30 220 LN with Epi 160 NO NO 2.40 10.4 10.2
335 Anitha C 23 1266 B Primi 1.57 60 24.34 37.4 YES 655 45 480 LN with Epi 810 YES YES 3.30 10.2 9.0
336 vidya S 25 1360 B Primi 1.52 64 27.70 37.4 YES 645 16 260 LN with Epi 180 NO NO 2.70 10.4 10.2
337 Deepa C 27 1369 B G2P1L1 1.54 55 23.19 38.2 YES 285 15 220 LN with Epi 90 NO NO 2.40 10.4 9.8
338 Rekaha S 22 1361 B Primi 1.53 62 26.49 38.4 YES 600 12 120 LN with Epi 75 NO NO 2.70 10.2 10.0
339 Rasi devi C 27 1367 B Primi 1.53 50 21.36 38.5 YES 685 30 320 LN with Epi 400 NO NO 2.60 9.8 9.2
340 Shanthi S 21 1371 B Primi 1.60 60 23.44 39.1 NO 565 15 210 LN with Epi 210 NO NO 2.50 10.2 10.0
341 Thilaka C 23 1384 B G2P1L1 1.64 62 23.05 38.2 YES 295 18 240 LN with LP 285 NO NO 2.50 10.4 9.6
342 Chithra S 25 1301 B G2P1L1 1.54 59 24.88 38.5 NO 255 15 130 LN with Epi 130 NO NO 3.00 9.8 9.6
343 Nirmala C 19 1380 B Primi 1.50 60 26.67 37.4 YES 600 35 280 LN with Epi 290 NO NO 3.10 9.8 9.2
344 Meena S 26 1397 B Primi 1.55 59 24.56 38.3 YES 655 40 300 LN with Epi 320 NO NO 3.70 10.0 9.8
345 Nirmala C 21 1400 B Primi 1.59 65 25.71 38.1 YES 675 45 380 LN with Epi 800 YES YES 2.70 10.2 9.0
346 Yuvarani S 21 1412 B Primi 1.50 70 31.11 39.1 YES 565 12 140 LN 60 NO NO 2.60 9.8 9.6
347 Menaka C 24 757 B Primi 1.45 48 22.83 37.4 YES 600 24 280 LN with Epi 360 NO NO 3.80 10.0 9.2
348 Bhavani S 20 1423 B Primi 1.55 63 26.22 38.2 YES 595 16 180 LN with Epi 140 NO NO 3.20 10.0 9.8
349 Amudha C 27 1408 B Primi 1.62 62 23.62 38.1 NO 560 24 160 LN with Epi 290 NO NO 2.60 10.4 9.8
350 Jansi rani S 27 1391 B Primi 1.60 66 25.78 39.3 YES 695 43 350 LN with Epi 750 YES YES 2.50 9.8 9.6
351 Jeya kodi C 22 1432 B G2P1L1 1.60 66 25.78 37.5 YES 320 16 280 LN with Epi 350 NO NO 3.00 10.2 9.4
352 Divya S 33 1428 B Primi 1.53 64 27.34 39.4 YES 575 18 220 LN with Epi 100 NO NO 2.90 10.6 10.2
353 Bhagya  lakshmi C 21 1434 B Primi 1.50 56 24.89 37.4 YES 585 25 240 LN with Epi 260 NO NO 2.60 10.8 10.2
354 Sayeed ali fathima S 32 1439 B G2P1L1 1.56 67 27.53 37.6 YES 295 20 220 LN with Epi 120 NO NO 3.10 10.2 10.0
355 Hemavathy C 19 1433 UB Primi 1.57 65 26.37 39.2 YES 655 23 260 LN with Epi 150 NO NO 2.70 10.4 9.8
356 Subhashini S 24 1441 B Primi 1.47 58 26.84 38.3 YES 645 20 220 LN with Epi 155 NO NO 3.30 10.2 9.6
357 Nandhini C 27 1443 B Primi 1.63 53 19.95 37.5 YES 710 32 340 LN with Epi 650 YES YES 3.40 10.4 9.2
358 Shakthi Uma S 21 1444 B Primi 1.54 64 26.99 38.5 YES 555 18 180 LN with LP 160 NO NO 3.20 10.8 10.6
359 Jeilani begum C 23 1447 B Primi 1.50 54 24.00 39.1 YES 675 25 300 LN with Epi 240 NO NO 2.90 10.6 10.0
360 Chinna ponnu S 26 1451 B primi 1.55 60 24.97 38.5 YES 245 14 220 LN with Epi 320 NO NO 2.90 9.8 9.4
361 Yasodha C 21 1454 B Primi 1.56 67 27.53 37.5 YES 560 22 180 LN with Epi 230 NO NO 2.50 10.4 9.8
362 Nirmala S 23 1445 UB Primi 1.58 58 23.23 39.2 YES 320 28 260 LN with Epi 440 NO NO 3.10 10.6 10.2
363 Arul mozhi C 21 1424 B Primi 1.60 81 31.64 37.4 YES 655 35 260 LN with Epi 275 NO NO 2.90 10.2 9.2
364 Gayathri S 26 1473 B Primi 1.56 57 23.42 39.3 YES 700 24 320 LN with Epi 360 NO NO 3.10 9.8 9.6
365 Renuka C 23 1134 B G2P1L1 1.46 60 28.15 38.6 YES 320 25 300 LN with Epi 270 NO NO 3.10 10.4 9.6
366 Namitha S 22 1259 B Primi 1.51 60 26.31 39.3 YES 565 21 100 LN with Epi 75 NO NO 2.70 10.6 10.4
367 Suganya C 21 1490 B Primi 1.50 61 27.11 38.2 YES 715 23 380 LN with Epi 270 NO NO 3.40 9.8 9.0
368 Devi S 27 1486 B Primi 1.50 48 21.33 39.1 YES 700 18 240 LN with Epi 180 NO NO 3.10 10.2 9.8
369 Durga C 22 1470 B Primi 1.46 59 27.68 37.4 NO 675 15 260 LN with Epi 280 NO NO 2.70 10.4 9.8
370 Revathi S 33 1475 B G3P2L2 1.50 57 25.33 38.6 YES 600 15 120 LN with Epi 120 NO NO 2.80 10.2 10.0
371 Sarala C 23 15169 B Primi 1.57 49 19.88 37.5 YES 650 32 355 LN with Epi 560 NO YES 3.50 10.6 10.0
372 Bharathi S 19 15497 B Primi 1.58 63 25.24 37.5 YES 645 25 280 LN with Epi 340 NO NO 3.10 10.2 9.8
373 Sandya C 27 15533 B G2P1L1 1.46 47 22.05 38.2 YES 320 32 350 LN with Epi 740 YES YES 3.10 9.8 8.8
374 Dhavamani S 22 15534 B G2P1L1 1.52 55 23.81 38.4 YES 285 12 200 LN with Epi 150 NO NO 2.40 10.4 10.2
375 Jeya Lakshmi C 19 15532 B Primi 1.54 59 24.88 38.5 YES 600 18 260 LN with Epi 250 NO NO 2.00 11.0 10.2
376 Sangeetha S 26 15545 B Primi 1.51 64 28.07 37.5 YES 540 14 80 LN with Epi 80 NO NO 2.10 10.2 10.0
377 Padmini C 21 15533 B Primi 1.57 64 25.96 39.2 YES 600 35 280 LN with Epi 140 NO NO 2.20 10.8 10.2
378 Tamilselvi S 23 15523 B Primi 1.51 49 21.49 37.4 YES 550 26 140 LN with LP 110 NO NO 2.30 10.2 10.0
379 Nazeema C 27 15438 B G2P1L1 1.45 49 23.31 39.1 YES 360 35 480 LN with LP 900 YES YES 3.20 10.8 9.0
380 Saranya S 21 15422 B Primi 1.47 54 24.99 38.2 YES 700 42 360 LN with Epi 330 NO NO 3.00 10.6 10.2
381 Bhakia Lakshmi C 22 15544 B G2P1L1 1.54 41 17.29 39.3 YES 360 36 310 LN with Epi 480 NO NO 2.40 9.8 9.2
382 Bavani S 26 15492 B Primi 1.51 67 29.38 37.5 YES 565 25 220 LN with Epi 210 NO NO 2.60 10.2 10.0
383 Sangeetha C 25 15540 B Primi 1.52 56 24.24 38.4 YES 600 28 290 LN with Epi 330 NO NO 2.40 10.4 10.0
384 Isai Vani S 23 15508 B G2P1L1 1.57 59 23.94 37.4 YES 300 30 340 LN with LP 220 NO NO 3.20 10.0 9.6
385 Menaga C 23 15504 B Primi 1.69 62 21.71 37.2 YES 675 35 310 LN with Epi 275 NO NO 2.30 10.2 9.2
386 Desammal S 33 15549 B G2P1L1 1.54 53 22.35 38.4 YES 670 26 280 LN with Epi 225 NO NO 2.30 10.6 10.4
387 Sumithra C 19 15603 B Primi 1.51 63 27.63 38.1 YES 655 25 240 LN with Epi 245 NO NO 2.60 11.0 10.4
388 Anitha S 24 15498 B G2P1L1 1.52 59 25.54 37.4 NO 300 30 250 LN 205 NO NO 2.50 10.4 10.2
389 Anitha C 21 15611 B Primi 1.52 62 26.84 38.2 NO 555 26 280 LN with Epi 255 NO NO 2.60 9.8 9.0
390 Shanthi S 27 15616 B Primi 1.64 62 23.05 38.1 YES 540 16 130 LN with Epi 240 NO NO 2.40 10.0 9.8
391 Sudha C 19 15589 B Primi 1.59 59 23.34 37.4 YES 560 15 140 LN 90 NO NO 2.40 10.4 9.8
392 Faritha Bee S 33 15613 B G2P1L1 1.53 59 25.20 39.1 YES 285 18 160 LN with Epi 240 NO NO 3.00 10.0 9.8
393 Hemalatha C 21 15513 B Primi 1.53 57 24.35 38.2 YES 655 32 280 LN with Epi 330 NO NO 2.90 9.6 9.0
394 Mariammal S 22 15618 B Primi 1.59 64 25.32 37.2 YES 625 14 140 LN 75 NO NO 2.60 10.2 9.8
395 Nithya C 24 15623 UB Primi 1.54 58 24.46 38.6 YES 695 25 340 LN with Epi 320 NO NO 3.30 11.0 10.4
396 Sherin S 28 15590 B G3P2L2 1.45 47 22.35 38.4 YES 265 12 130 LN with Epi 210 NO NO 3.70 10.5 10.2
397 Latha C 21 15600 B Primi 1.49 69 31.08 37.4 YES 710 42 380 LN 450 NO NO 2.50 10.2 9.8
398 Parvathy S 23 15596 B Primi 1.63 55 20.70 37.3 YES 665 38 340 LN with Epi 700 YES YES 3.50 10.4 9.0
399 Mohana C 22 15633 B Primi 1.54 62 26.14 39.1 YES 675 28 420 LN with Epi 310 NO NO 3.00 10.8 10.0
400 Naveena S 28 15662 B Primi 1.59 65 25.71 37.4 YES 555 24 240 LN with Epi 110 NO NO 2.90 10.0 9.8
S -  Study G2P1L1 -    Gravida two  para one Live one
C -   Control G3P2L2 -    Gravida three Para two Live two
B -     Booked G.Age - Gestational Age
UB -   Un Booked BMI - Body Mass Index
LN -   Labour Natural
L N with Epi  -    Labour Natural with Episiotomy
LN with LP  -   Labour Natural with Perineal Laceration
